Gene	site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
results, phosphosites to test:
AAK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Abls, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ARHGDIB	130	14	95.2	0	X	X
PLK1	425	14	92.6	0	X	X
RTCB	306	14	98.3	0	X	X
CTNNB1	654	13	96.6	0	X	X
DDB1	182	13	96.1	0	X	-
MYLK	792	13	85.5	0	-	X
MYLK	231	13	88.2	0	-	X
RTCB	316	13	97.8	0	X	X
KAT5	44	12	92.3	0	-	X
MAVS	71	12	96.4	0	X	-
MDM4	55	12	93.7	0	X	-
VAV1	174	12	88.0	0	-	X
VAV1	267	12	95.9	0	-	X
CAT	231	11	98.9	0	X	X
CRK	239	11	77.2	0	X	X
CTNNB1	489	10	98.7	0	-	X
CAT	386	0	98.6	5	X	X
PSMA7	106	7	98.3	0	X	-
PSMA7	153	9	98.3	0	X	X
LGALS3	118	6	98.2	0	X	X
TBX21	305	7	98.0	3	X	X
RAD51	315	8	97.8	0	X	-
KAT5	294	10	97.5	0	X	X
SNW1	292	9	97.0	0	X	-
TBX21	266	10	96.8	0	X	X
DDB1	718	7	96.7	2	X	-
ATR	291	10	81.2	0	X	X
ATR	310	7	79.8	0	X	X
CASP9	153	8	91.7	0	X	X
CDC73	293	5	67.2	0	X	-
CDKN1B	88	4	91.9	0	X	X
CDKN1B	89	5	91.7	0	-	X
CRK	251	2	65.8	0	X	X
CTNNB1	86	9	68.0	0	X	X
DCBLD2	666	2	53.1	0	X	-
MAVS	9	11	96.0	0	X	-
DNM1L	266	10	91.6	0	X	X
PDGFRB	970	9	87.3	0	X	-
SNCA	39	9	91.4	0	X	X
TRIM33	524	9	76.0	0	X	-
NOX5	478	11	91.3	0	X	-
ERRFI1	394	10	95.7	0	X	-
ERRFI1	395	9	94.7	0	X	-
NOX5	476	11	90.6	0	X	-
MYLK	464	8	82.0	0	X	X
CDC73	315	2	61.2	1	X	-
FHL2	176	8	94.9	0	X	-
MET	1356	2	62.0	13	-	X
PDGFRB	686	7	91.2	0	X	-
PIK3AP1	553	5	50.1	0	X	-
PLCG1	1003	11	96.2	0	X	-
Acks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ATP5F1A	246	14	98.3	0	X	X
ATP5F1A	243	9	98.0	0	X	X
TNK2	860	6	62.3	0	-	X
TNK2	859	5	64.9	0	-	X
TNK2	284	3	84.7	0	-	X
AR	365	0	54.0	117	X	-
AR	269	0	32.9	21	X	-
AR	535	0	36.9	14	X	-
ADCK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Akt1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AR	792	15	95.8	0	X	X
TKT	387	15	98.6	0	X	-
RPS3A	88	14	93.7	0	X	-
AKT1	72	11	91.3	0	-	X
NCF1	328	11	91.0	0	-	X
NQO1	40	11	98.9	0	-	X
RUNX2	200	11	98.0	0	-	X
PHB2	176	10	91.9	0	X	X
TKT	382	10	97.7	1	-	X
BECN1	234	9	98.4	0	X	-
HES5	35	9	96.1	0	X	-
HES5	34	9	96.3	0	X	-
HSF1	142	9	85.8	0	-	X
KDM5A	1255	9	92.8	0	-	X
LMNA	301	9	96.0	0	X	-
NQO1	128	7	98.5	1	X	X
PKM	97	9	98.5	0	-	X
STK3	117	5	98.2	2	X	X
RUNX2	198	9	98.1	2	-	X
STK4	120	5	98.1	2	X	X
RUNX2	196	6	97.8	2	-	X
AKT1	246	6	97.1	1	-	X
TWIST1	121	9	96.9	0	X	X
TWIST1	123	9	96.4	0	X	X
BECN1	295	4	87.0	0	X	X
BTK	51	8	88.1	0	X	-
BTK	495	7	90.7	0	X	-
CARD11	644	7	54.8	0	-	X
DLC1	735	2	32.0	0	X	X
DLC1	1004	6	41.5	0	X	X
IWS1	721	4	47.1	0	-	X
IWS1	720	6	51.6	0	-	X
NF2	518	9	79.3	0	X	-
PTK2	695	9	83.2	0	X	X
TBC1D4	568	9	44.5	0	-	X
KDM5A	1225	8	91.6	0	-	X
PHB2	91	9	93.9	0	X	X
NCL	641	7	83.6	0	X	-
TERT	824	7	84.0	0	-	X
PKM	202	4	95.4	0	-	X
NF2	230	5	90.2	1	X	-
PKM	37	4	96.1	1	-	X
CDKN1A	146	3	71.7	1	X	X
TBC1D4	570	9	43.0	0	-	X
VCP	352	6	87.3	0	X	X
YBX1	102	5	93.1	3	X	X
BRAF	365	4	55.7	68	-	X
ESR1	305	6	81.7	1	-	X
FOXO1	24	2	51.2	2	X	X
LONP1	173	2	80.2	0	X	X
Akt2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAT1A	180	14	98.8	0	X	-
IRF3	207	13	97.1	0	X	-
MAT1A	202	12	98.6	0	X	-
PHB2	176	10	91.9	0	-	X
IRF3	14	9	92.3	0	X	-
PHB2	91	9	93.9	0	-	X
ATP7A	1463	8	38.3	0	X	X
ATP7A	1424	6	53.0	0	X	X
ATP7A	1466	5	35.6	0	X	X
HSF1	326	4	52.5	1	-	X
PKP1	54	4	49.4	1	X	X
PKP1	118	3	58.5	1	X	X
PKP1	121	2	29.0	1	X	X
PKP1	119	2	61.8	0	X	X
PKP1	56	1	41.2	3	X	X
IRS2	1149	0	48.6	274	-	X
IRS2	365	0	43.2	66	-	X
WIPF1	398	0	42.9	51	X	X
WIPF1	154	0	41.9	22	X	-
H3C1	10	0	None	100000	-	X
H3C1	28	0	None	100000	-	X
H3C1	45	0	None	100000	X	X
HSF1	230	0	39.9	28	X	X
IRF3	180	0	36.2	11	X	-
IRF3	175	0	36.7	16	X	-
Akt3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NCF1	328	11	91.0	0	X	-
IWS1	720	6	51.6	0	X	X
BRAF	365	4	55.7	68	X	X
IWS1	721	4	47.1	0	X	X
NCF1	304	2	94.8	0	X	-
BRAF	429	0	39.4	4	X	X
EMSY	207	0	39.0	19	-	X
EMSY	209	0	36.0	21	-	X
ALK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ENG	646	0	47.8	29	X	-
ENG	640	0	46.3	23	-	X
ENG	654	0	44.6	37	-	X
ENG	649	0	51.2	32	X	-
ALK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TDP2	88	0	42.0	23	-	X
TDP2	92	0	41.2	19	-	X
ALKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PTPN11	542	7	57.1	0	X	-
ALK	1278	4	49.1	0	-	X
ALK	1604	0	30.0	94	X	-
PTPN11	580	0	33.2	36	X	-
AlphaK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TIFA	177	0	69.9	24	-	X
TIFA	9	0	73.7	4	-	X
AlphaK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AMPKA1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CD274	195	12	98.1	0	X	X
STIM1	257	11	78.2	0	-	X
NOS3	1177	10	67.4	0	X	-
PRKAB1	80	10	95.8	0	-	X
FOXO3	179	9	94.0	0	X	X
KCNA5	592	9	50.6	0	X	X
NOS3	1179	9	60.8	0	X	-
PDHA1	314	9	98.5	0	X	X
PPP2R5C	336	9	94.2	0	-	X
SCFD1	316	9	91.3	0	X	X
JAK1	518	8	95.6	1	-	X
TP53	20	8	64.0	0	-	X
CFTR	813	7	33.6	0	X	X
FOXO3	626	7	68.3	0	X	X
PPP2R5C	298	7	96.8	0	-	X
PDHA1	295	2	98.0	0	X	X
JAK1	515	6	95.0	1	-	X
PRKAB1	108	6	95.0	0	-	X
PRKAB1	148	5	94.2	1	-	X
PRKAB1	158	6	92.2	0	-	X
PRKAA1	183	2	86.4	5	X	X
YAP1	94	4	81.0	0	X	X
BECN1	388	5	72.6	0	X	X
FOXO1	22	2	52.1	0	-	X
FOXO3	30	3	58.7	0	-	X
KLC2	545	5	46.9	0	-	X
KLC2	582	4	34.1	0	-	X
HIPK2	121	6	68.0	1	-	X
RPTOR	792	6	50.4	0	X	X
YAP1	61	7	69.4	0	X	X
BECN1	93	0	34.6	16	X	-
BECN1	96	0	35.0	13	X	-
BECN1	90	0	35.2	19	X	-
CD274	283	3	52.5	2	X	X
CFTR	737	0	27.9	32	-	X
TP53	18	7	58.3	0	-	X
CFTR	768	2	33.9	1	-	X
EGLN1	61	2	70.0	4	X	X
HIPK2	119	2	66.3	3	-	X
NOS3	633	5	39.9	2	X	-
PRKAA1	388	4	47.5	0	-	X
PRKAB1	177	5	60.7	0	-	X
TNNI3	24	2	51.4	2	-	X
AMPKA2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FOXO3	179	9	94.0	0	X	-
PDHA1	314	9	98.5	0	X	-
GLI1	102	8	64.1	1	X	X
FOXO3	626	7	68.3	0	X	-
HIPK2	121	6	68.0	1	X	-
PINK1	228	5	92.4	2	X	-
PINK1	284	4	94.3	1	X	-
IKBKB	177	3	67.2	1	X	X
IKBKB	181	3	71.2	2	X	X
PINK1	495	3	97.0	0	X	-
HIPK2	119	2	66.3	3	X	-
PDHA1	295	2	98.0	0	X	-
FOXO3	555	0	38.7	58	X	-
FOXO3	588	0	35.5	25	X	-
FOXO3	413	0	39.0	23	X	-
FOXO3	399	0	45.7	9	X	-
GLI1	1074	0	41.3	14	X	X
HDAC5	498	0	35.6	7	X	-
GLI1	408	0	37.7	13	X	X
HDAC5	259	0	39.0	65	X	-
AMPKB1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
STIM1	257	11	78.2	0	X	X
PDHA1	314	9	98.5	0	-	X
PDHA1	295	2	98.0	0	-	X
STIM1	521	0	40.7	61	X	X
AMPKG2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
STIM1	257	11	78.2	0	-	X
PDHA1	314	9	98.5	0	-	X
PDHA1	295	2	98.0	0	-	X
STIM1	521	0	40.7	61	-	X
ARAFs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BAD	118	9	83.4	0	-	X
MAP2K1	222	9	67.2	0	X	X
MAP2K1	218	8	77.3	0	X	X
BAD	99	0	64.6	3	-	X
BAD	75	0	56.7	17	-	X
Args, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CAT	231	11	98.9	0	X	X
MICAL2	488	11	95.4	0	X	X
MICAL2	445	10	96.4	0	X	X
LGALS3	118	6	98.2	0	X	X
MICAL2	463	5	96.7	1	X	X
ABL2	261	4	85.7	0	-	X
ABL2	439	3	80.3	0	-	X
CAT	386	0	98.6	5	X	X
CRK	221	0	35.0	12	-	X
CRK	222	0	None	100000	-	X
LGALS3	79	0	44.2	39	X	X
ASK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPRE1	40	12	95.1	0	X	X
SIAH1	235	10	98.4	0	X	X
STRAP	179	10	98.1	0	-	X
MAPRE1	206	9	87.1	0	X	X
STRAP	175	9	97.3	0	-	X
SIAH1	239	7	97.4	1	X	X
ZNF622	318	7	90.0	0	X	X
MAP3K5	813	6	90.0	0	-	X
DAXX	184	5	89.2	1	X	X
SIAH1	74	4	95.8	0	X	X
MAP3K5	842	3	85.8	1	-	X
SIAH1	70	2	94.6	2	X	X
ZNF622	314	2	85.9	3	X	X
MAP3K5	838	1	56.1	3	-	X
DAXX	176	0	40.4	9	X	X
MAPK14	180	0	57.0	4	X	-
MAP3K5	966	0	28.6	24	-	X
MAPK14	182	0	56.1	5	X	-
MAPK8	185	0	50.8	5	X	-
MAPK8	183	0	34.9	6	X	-
ATMs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MRE11	264	13	97.6	0	-	X
ATM	440	12	88.2	0	-	X
MDC1	98	11	95.1	0	X	X
CREB1	107	9	86.8	0	X	X
HUWE1	927	9	94.7	1	X	-
RANBP9	181	9	98.4	0	X	X
RNF20	172	9	81.9	0	X	X
RNF40	853	9	82.5	0	X	-
RNF40	819	9	90.7	0	X	-
RNF40	114	9	59.6	0	X	X
TAOK1	643	9	96.4	0	-	X
TAOK1	785	9	93.3	0	-	X
TAOK3	551	9	88.5	0	X	-
TP53BP1	1778	9	81.1	0	X	-
UBR5	191	9	90.9	0	X	-
NKX3-1	166	6	98.4	0	X	-
PTEN	113	7	98.4	0	X	X
NKX3-1	134	6	98.3	0	X	-
DYRK2	442	4	97.5	1	X	-
TDP1	365	7	97.5	0	X	-
XPA	196	7	96.4	1	-	X
CREB1	119	6	94.9	0	X	X
XPA	173	2	93.9	0	-	X
SARS1	101	6	92.8	0	X	X
ATM	367	6	56.3	0	X	X
BRCA1	1423	5	53.9	0	X	X
CBL	866	7	90.8	0	X	X
DDX1	377	7	87.4	0	X	X
FANCD2	222	6	87.6	0	X	X
FANCI	1121	2	34.8	0	X	-
FANCI	559	3	35.0	0	X	-
FANCI	556	4	34.8	0	X	-
KHSRP	274	2	56.9	0	X	X
NBN	278	2	56.7	0	X	X
TOPBP1	1062	7	48.3	0	-	X
BAG6	26	5	86.1	1	X	-
DDX1	671	3	89.7	4	X	X
XRCC6	33	1	63.2	4	X	-
ABRAXAS1	406	0	62.4	96	X	-
ABRAXAS1	404	0	58.8	94	X	-
ATF2	490	0	40.4	10	X	-
ATF2	498	0	47.2	18	X	-
ATM	1885	0	None	100000	-	X
ATM	2996	0	None	100000	X	X
ATM	1893	0	None	100000	X	X
TOPBP1	554	6	82.0	0	-	X
RANBP9	603	6	47.3	0	X	X
TOPBP1	1138	3	58.8	0	-	X
TP53	15	4	53.9	1	X	X
DCLRE1C	656	2	51.8	1	X	-
FANCD2	691	2	69.4	1	X	-
FANCI	972	5	85.6	1	X	-
ATRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ATRIP	68	9	80.6	0	X	X
FANCD2	608	9	84.9	0	-	X
RPA2	72	8	86.4	1	-	X
SARS1	241	7	89.0	0	X	X
XPA	196	7	96.4	1	X	X
RPA2	52	6	97.1	0	-	X
SARS1	101	6	92.8	0	X	X
SMC1A	966	6	57.8	0	X	-
ATRIP	72	5	70.2	0	X	X
BRCA1	1423	5	53.9	0	X	X
RPA2	174	5	64.1	0	-	X
FANCI	556	4	34.8	0	-	X
TP53	15	4	53.9	1	X	X
FANCI	559	3	35.0	0	-	X
SIRT7	134	3	73.8	2	X	-
XPA	173	2	93.9	0	-	X
FANCD2	691	2	69.4	1	X	X
SIRT7	136	0	60.0	4	X	-
CDKN2A	152	0	56.5	16	X	-
CHEK1	317	2	33.7	0	X	X
MCC	118	2	36.3	1	X	-
BLM	99	0	31.0	58	-	X
BLM	122	0	26.4	35	-	X
BRCA1	1280	0	29.5	32	-	X
BRCA1	1524	0	29.4	101	X	-
BRCA1	1143	0	27.7	169	-	X
BRCA1	1457	0	34.4	34	X	-
CDKN2A	7	0	49.4	4	X	-
CDKN2A	140	0	46.6	4	X	-
CDKN2A	8	0	48.5	3	X	-
FANCD2	717	1	32.4	3	X	X
AurAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AURKA	148	15	96.7	0	-	X
CRMP1	101	14	98.5	0	-	X
CRMP1	102	13	98.5	0	-	X
TP53	215	12	96.7	0	X	X
ALDH1A1	267	11	98.8	0	X	X
SDCBP	200	11	95.1	0	X	X
AURKA	278	10	83.2	1	-	X
AURKA	342	10	95.0	0	-	X
SDCBP	131	10	96.6	0	X	X
ALDH1A1	493	9	98.8	0	X	X
ALDH1A1	442	9	98.7	0	X	X
KCTD12	243	9	94.8	0	X	-
SPIN1	109	9	97.7	0	X	X
AURKA	391	8	86.6	1	-	X
LATS2	83	8	61.1	0	X	X
RUNX3	173	7	97.8	0	X	-
AURKA	266	5	97.7	0	-	X
TP53	106	6	97.2	0	X	X
NFKBIA	262	7	96.5	1	-	X
MAP9	625	6	57.3	0	X	X
AURKA	226	4	88.0	1	-	X
ESR1	305	6	81.7	1	X	X
AURKA	287	2	61.6	5	-	X
MBD3	24	3	86.2	2	X	X
NFKBIA	63	4	69.5	1	-	X
AurBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SSU72	19	13	98.5	0	X	X
TP53	215	12	96.7	0	X	X
HSP90AB1	452	10	96.6	0	-	X
TP53	269	10	97.6	0	X	X
BIRC5	117	9	97.7	0	X	X
CDCA5	139	9	79.3	0	X	X
CDCA8	275	9	83.6	0	-	X
CDT1	143	9	77.3	0	-	X
CKAP2	628	9	85.8	0	X	X
CKAP2	39	9	73.3	0	-	X
LMO7	751	9	79.8	0	-	X
NINL	448	9	96.0	0	X	X
TP53	284	9	94.6	0	X	X
BIRC5	34	7	97.1	1	-	X
HMGN2	25	7	69.2	0	X	X
RUNX3	173	7	97.8	0	X	-
NFKBIA	262	7	96.5	1	-	X
RACGAP1	387	7	96.4	2	X	X
HNRNPU	14	6	93.6	0	X	-
HNRNPU	26	3	93.5	2	X	-
SEPTIN1	253	5	86.9	0	-	X
TP53	211	3	86.0	0	X	X
CDCA8	278	6	78.5	0	-	X
INCENP	894	3	63.5	0	X	X
INCENP	893	3	64.5	0	X	X
RBM14	618	3	47.5	0	-	X
CDCA8	219	4	65.1	2	-	X
AURKB	16	0	30.0	20	-	X
AURKB	7	0	31.1	29	-	X
AURKB	232	2	65.9	2	X	X
CDCA2	977	0	35.5	75	X	X
CDCA2	893	0	51.9	8	X	X
SEPTIN1	312	7	45.5	0	-	X
CDCA5	159	2	60.1	1	X	X
CDCA5	164	4	66.8	1	X	X
INCENP	494	2	51.8	1	-	X
NFKBIA	63	4	69.5	1	-	X
PLEKHG6	620	2	30.1	2	-	X
AurCs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NFKBIA	262	7	96.5	1	X	X
INCENP	892	4	69.3	1	-	X
NFKBIA	63	4	69.5	1	X	X
INCENP	894	3	63.5	0	-	X
INCENP	893	3	64.5	0	-	X
NFKBIA	32	1	60.3	3	X	X
AXLs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AKT1	473	7	82.0	1	X	-
AKT1	308	2	72.1	2	X	-
ELMO1	724	0	65.9	21	-	X
ELMO1	720	0	79.9	17	X	X
BCKDKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BCR-ABL1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ABL1	257	15	90.9	0	X	-
RHOA	66	7	94.1	0	X	-
ABL1	253	4	74.6	2	X	-
ABL1	232	3	91.5	0	X	-
BCR	177	0	43.1	7	-	X
BCR	360	0	32.8	120	X	X
BCR	328	0	26.2	112	X	-
BCR	283	0	26.3	67	-	X
RHOA	34	0	92.1	5	X	-
Bcrs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BIKEs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BLKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FCGR2A	304	0	47.8	5	-	X
FCGR2A	288	0	47.6	3	-	X
BMPR1Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SMAD1	465	0	87.2	11	X	X
SMAD1	462	0	85.6	8	X	X
SMAD1	463	0	86.4	9	X	X
SMAD2	467	0	84.8	12	X	-
SMAD2	465	0	85.2	10	X	-
SMAD2	464	0	85.1	9	X	-
BRAFs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EEF1A1	88	12	86.6	0	-	X
EEF1A1	21	10	83.9	0	-	X
BAD	118	9	83.4	0	X	X
MAP2K1	222	9	67.2	0	X	X
BRAF	465	8	67.1	0	-	X
MAP2K1	218	8	77.3	0	X	X
MAP2K2	222	8	79.5	0	-	X
MAP2K2	226	8	66.5	0	-	X
BRAF	467	5	54.1	0	-	X
BAD	134	2	59.3	1	X	X
BAD	99	0	64.6	3	X	X
BAD	75	0	56.7	17	X	X
BRAF	614	0	47.4	3	X	-
BRAF	373	0	28.3	60	-	X
TTK	281	0	32.2	71	X	-
TTK	436	0	33.9	25	X	-
BRD4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Brks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CTNNB1	142	11	88.0	0	-	X
AKT1	326	7	79.0	0	X	X
BCAR1	664	7	51.7	0	X	X
CTNNB1	331	7	98.7	1	-	X
AKT1	315	6	93.0	0	X	X
CTNNB1	333	5	98.7	1	-	X
PTK6	447	4	80.1	3	-	X
PTK6	342	4	91.3	0	-	X
BCAR1	165	0	36.7	52	X	X
CTNNB1	64	0	29.5	12	-	X
BRSK1 iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BRSK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TUBG1	385	12	94.3	0	-	X
TUBG1	131	3	90.4	1	-	X
BRSK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Btks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TIRAP	86	10	93.2	0	-	X
PLCG2	1217	9	71.2	0	X	-
TIRAP	106	9	94.9	0	-	X
BTK	551	8	76.3	0	X	X
IKZF1	215	8	81.3	0	X	-
TIRAP	187	7	92.0	1	-	X
BTK	223	6	86.0	2	X	X
IKZF1	214	6	81.7	0	X	-
PLCG2	753	1	37.1	2	X	X
NFKBIA	305	0	50.9	6	X	X
NFKBIA	289	0	45.2	11	-	X
PLCG2	759	0	35.9	3	X	X
BUB1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BUB1	960	9	91.4	0	-	X
CDC20	92	9	74.8	0	-	X
BUB1	148	7	74.6	0	-	X
BUB1	752	6	94.5	0	-	X
BUB1	525	5	39.7	0	-	X
CDC20	161	4	70.1	13	-	X
BUB1	969	3	71.1	0	-	X
CDC20	153	2	61.0	5	-	X
BUB1	589	0	34.8	8	-	X
BUB1	563	0	36.2	34	-	X
BUB1	510	0	26.9	3	-	X
BUB1	667	0	28.0	50	-	X
BUB1	552	0	35.1	27	-	X
BUB1	213	0	41.9	26	-	X
BUB1	419	0	32.5	46	-	X
CDC20	157	0	51.9	9	-	X
CDC20	72	0	43.4	11	-	X
CDC20	41	0	42.8	5	-	X
BUB1	198	0	35.4	41	-	X
BUB1	176	0	35.2	21	-	X
BUB1	511	0	28.0	4	-	X
BUB1	454	0	33.3	11	-	X
BUB1	618	0	33.1	11	-	X
BUB1	679	0	34.3	38	-	X
BUB1	173	0	32.0	18	-	X
BVRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BLVRA	72	13	98.7	0	-	X
BLVRA	83	10	98.7	0	-	X
CAMK1As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GCM1	47	12	96.2	0	X	X
GCM1	174	5	63.3	0	-	X
CDKN1B	157	0	56.2	60	X	X
CDKN1B	198	0	69.3	101	X	X
GCM1	177	0	50.6	3	-	X
GCM1	178	0	47.0	4	-	X
GCM1	269	0	36.7	95	-	X
HDAC5	498	0	35.6	7	X	-
HDAC5	259	0	39.0	65	X	-
HDAC9	220	0	38.3	62	X	-
HDAC9	451	0	35.6	5	X	-
CAMK1Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HSP90AA1	391	9	90.5	0	X	X
HSP90AA1	624	7	75.5	0	X	X
CAMK1Gs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CAMK2As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CAMK2A	306	12	65.2	0	-	X
CTNNB1	472	12	98.6	0	-	X
CAMK2A	286	11	93.2	0	X	X
CAMK2A	305	11	59.1	0	-	X
HRH1	398	9	78.7	0	-	X
HRH1	396	9	80.3	0	-	X
SCN5A	1925	9	56.5	0	-	X
SCN5A	1920	9	65.8	0	-	X
SCN5A	667	9	49.0	0	-	X
SCN5A	664	9	46.5	0	-	X
SLC1A3	26	9	76.2	0	-	X
KCNJ11	180	8	92.5	0	X	X
AKAP5	87	7	59.8	0	-	X
CTNNB1	552	7	75.3	0	-	X
CYLD	772	7	95.3	2	X	X
CTNNB1	332	4	98.7	2	-	X
HRH1	142	6	94.7	0	-	X
KCNJ11	224	6	92.9	0	X	X
HRH1	140	7	91.1	1	-	X
RCHY1	154	2	90.5	3	X	X
RCHY1	155	1	90.4	4	X	X
SCN5A	20	7	84.0	0	-	X
SCN5A	17	5	83.4	1	-	X
SCN5A	12	4	67.4	0	-	X
SCN5A	61	5	74.4	0	-	X
SCN5A	11	3	66.4	0	-	X
CYLD	418	1	54.5	49	X	X
AKAP5	92	0	48.7	3	-	X
BECN1	96	0	35.0	13	X	-
BECN1	93	0	34.6	16	X	-
BECN1	90	0	35.2	19	X	X
SMAD2	110	4	55.3	1	X	X
SCN5A	1503	5	57.8	1	-	X
SCN5A	42	6	46.2	0	-	X
SCN5A	1934	1	38.1	2	-	X
SCN5A	1865	5	60.9	1	-	X
SLC1A3	37	5	70.6	1	-	X
CAMK2Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ITGB1	789	0	70.7	4	-	X
ITGB1	788	0	70.2	5	-	X
CAMK2D iso8s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CAMK2Ds, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KCNQ1	482	0	37.9	21	X	X
KCNQ1	484	0	44.0	19	X	X
SCN5A	594	0	27.4	63	-	X
SCN5A	516	0	31.2	63	-	X
TTN	11922	0	None	100000	-	X
TTN	12022	0	None	100000	-	X
TTN	11932	0	None	100000	-	X
TTN	11969	0	None	100000	-	X
TTN	11878	0	None	100000	-	X
CAMK2Gs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CAMK2G	319	9	47.5	0	-	X
CAMK2G	280	3	96.2	2	-	X
CAMK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NOVA2	194	10	91.5	0	X	-
HDAC5	498	0	35.6	7	X	X
HDAC5	259	0	39.0	65	X	X
NOVA2	27	0	40.4	3	X	-
NOVA2	25	0	36.4	5	X	-
CAMKK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CAMK4	200	4	38.5	1	-	X
CAMK4	12	0	33.7	23	-	X
CAMK4	13	0	34.0	22	-	X
CAMKK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SIRT1	47	0	38.8	25	X	X
SIRT1	27	0	40.7	45	X	X
caMLCKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CASKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CASK	155	2	92.2	0	-	X
CASK	151	1	92.5	2	-	X
CDC7s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDC7	216	9	66.5	0	-	X
MCM2	220	9	87.5	0	-	X
DBF4	312	8	96.1	1	-	X
MCM2	108	6	76.9	0	X	X
CLSPN	1147	5	55.6	0	-	X
TOP2A	1213	5	83.7	1	X	X
CLSPN	1129	4	54.0	0	-	X
MCM2	53	2	36.6	0	X	X
CDC7	277	0	29.3	52	-	X
CDC7	296	0	29.1	51	-	X
CDC7	318	0	34.3	29	-	X
CDC7	239	0	38.8	14	-	X
CDC7	285	0	28.6	60	-	X
CDC7	297	0	30.5	50	-	X
CLSPN	260	0	33.3	13	-	X
DTD1	205	0	55.6	29	X	-
DTD1	204	0	55.1	28	X	-
DTD1	197	0	52.8	21	X	-
DTD1	196	0	52.5	20	X	-
DTD1	194	0	49.5	18	X	-
NPM1	137	0	47.2	5	-	X
NPM1	199	0	46.4	45	-	X
DTD1	179	0	44.8	3	X	-
DTD1	181	0	42.5	5	X	-
DTD1	182	0	42.8	6	X	-
MCM2	139	0	35.1	9	X	X
DTD1	187	0	42.2	11	X	-
MCM2	41	0	36.8	11	-	X
CLSPN	110	0	39.3	59	-	X
CLSPN	721	0	33.4	59	-	X
CLSPN	67	0	37.3	102	-	X
CLSPN	704	0	41.8	42	-	X
CDK10s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ETS2	220	0	36.6	35	-	X
ETS2	225	0	36.0	40	-	X
CDK11A iso10s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK11As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SPDEF	243	4	70.5	8	X	X
SPDEF	242	1	60.1	9	X	X
SPDEF	238	0	36.4	13	X	X
CDK11Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK12s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PAK2	134	8	55.7	0	X	X
PAK2	169	0	33.3	19	X	X
POLR2A	1616	0	32.8	86	X	X
POLR2A	1619	0	35.3	89	-	X
CDK13s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
POLR2A	1616	0	32.8	86	-	X
POLR2A	1619	0	35.3	89	-	X
CDK14s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CCNY	73	13	88.4	0	X	X
CCNY	67	9	92.7	1	-	X
CCNY	71	8	91.7	0	X	X
CCNY	83	8	54.9	0	-	X
CCNY	288	6	86.7	2	-	X
CCNY	295	4	87.2	1	-	X
TAGLN2	83	4	93.6	3	X	-
TAGLN2	163	4	88.2	1	X	-
CDK15s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK16s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK18s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RB1	807	2	52.4	1	-	X
RB1	811	2	43.6	2	-	X
RB1	795	1	52.7	6	-	X
CDK19s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EIF3F	119	15	89.2	0	X	X
EIF3F	46	0	33.3	41	X	X
NOTCH1	2513	0	28.5	34	X	X
NOTCH1	2511	0	27.6	36	X	X
NOTCH1	2516	0	29.9	31	X	-
CDK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BLM	714	11	89.4	1	-	X
NME1	120	11	98.3	1	-	X
RCC1	387	11	97.7	0	-	X
BARD1	148	10	72.5	0	-	X
DDX3X	323	10	93.1	1	-	X
BLM	766	9	90.5	1	-	X
BUB1B	1043	9	58.2	1	-	X
CDCA5	139	9	79.3	0	X	X
EIF2AK2	456	8	91.3	1	X	-
FLNA	1459	8	79.1	1	-	X
ITPR1	421	8	80.7	0	-	X
PHF8	120	8	94.1	1	-	X
SIRT3	150	8	92.7	0	X	X
AKT1	473	7	82.0	1	X	-
DENR	69	7	54.1	0	-	X
TOP1	394	0	98.2	4	-	X
NME1	94	4	98.1	2	-	X
NDUFA12	120	4	97.0	1	X	X
RCC1	274	5	96.1	2	-	X
NCAPG	332	6	94.1	1	-	X
NCAPG	308	7	93.5	1	-	X
SLX4	1571	6	92.2	0	-	X
NDUFA12	142	0	92.1	20	X	X
AR	83	6	54.1	0	X	-
CDC27	446	5	54.6	0	X	X
DLGAP5	618	7	76.6	0	-	X
EIF2AK2	83	6	54.7	0	X	-
FERMT1	174	2	30.0	0	X	-
NCL	641	7	83.6	0	X	X
OSBP2	762	6	83.9	0	-	X
OSBP2	763	3	77.2	0	-	X
PHF8	69	6	89.1	0	-	X
TEX14	728	6	52.9	0	X	-
MASTL	194	5	69.8	1	X	-
NDUFB6	55	5	88.4	1	X	X
RB1	373	5	81.6	1	-	X
TEX14	727	5	49.8	0	X	-
FLNA	1533	7	84.6	1	-	X
FLNA	1630	5	85.2	1	-	X
FLNA	1084	6	76.7	1	-	X
FLNA	1436	5	85.0	1	-	X
USP24	1616	7	57.7	0	X	-
EIF4EBP1	83	4	85.1	1	X	X
KPNA2	9	7	45.0	1	X	X
SIRT3	159	3	81.9	1	X	X
BORA	112	2	60.7	1	X	X
CDCA5	159	2	60.1	1	X	X
CDCA5	164	4	66.8	1	X	X
CDK20s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BARD1	148	10	72.5	0	-	X
NR1I2	350	10	98.2	1	X	X
RB1	567	10	97.1	1	-	X
EEF2	595	9	95.4	1	X	X
NR1I2	200	9	88.8	0	-	X
NCOA1	325	8	94.1	1	-	X
POLL	553	8	97.2	3	-	X
DENR	69	7	54.1	0	-	X
ESR1	341	7	92.1	0	-	X
NRF1	136	7	88.1	0	-	X
HNRNPK	216	6	84.0	1	X	X
MCM2	108	6	76.9	0	-	X
NR1I2	133	6	58.6	0	-	X
NRF1	102	6	89.5	0	-	X
RB1	821	6	40.3	1	X	X
NR1I2	167	5	96.6	0	-	X
TSPYL2	340	6	96.0	1	-	X
TFCP2	258	5	93.2	1	-	X
EEF2	435	4	90.0	1	-	X
NPM1	70	5	90.0	1	-	X
RB1	780	4	89.1	8	X	-
MCM2	53	2	36.6	0	-	X
CCNE1	387	4	63.3	1	-	X
CCP110	400	4	57.6	1	X	X
CDK7	170	2	38.1	1	-	X
CDK7	164	5	43.8	1	-	X
RB1	608	6	80.4	2	-	X
RB1	373	5	81.6	1	-	X
FZR1	163	4	79.5	1	-	X
NR1I2	114	4	86.9	1	-	X
RB1	807	2	52.4	1	X	X
RB1	811	2	43.6	2	X	X
AKT1	477	1	64.0	2	X	X
LARP1	649	1	57.1	2	-	X
STMN1	25	1	77.0	2	-	X
AKIRIN2	21	0	44.5	47	-	X
AKIRIN2	18	0	48.0	50	-	X
RBL2	1080	5	81.2	1	X	-
ITGB3BP	33	5	79.0	1	-	X
RBBP8	847	3	70.5	2	X	X
ETAA1	111	2	64.6	1	X	X
GIGYF2	593	5	81.4	1	-	X
MYBL2	520	3	52.6	1	-	X
NPAT	1350	3	47.8	2	X	X
NR1I2	135	4	49.8	1	-	X
CDK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
JUN	73	5	63.4	0	X	X
RB1	807	2	52.4	1	X	-
RB1	811	2	43.6	2	X	-
ESR1	104	0	34.8	80	X	X
ESR1	118	0	33.4	66	X	X
ESR1	106	0	35.0	78	X	X
JUN	63	0	49.4	10	X	X
NOTCH1	2513	0	28.5	34	X	X
NOTCH1	2511	0	27.6	36	X	X
NOTCH1	2516	0	29.9	31	X	-
CDK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FLNA	1459	8	79.1	1	X	-
WDR77	306	8	96.7	1	-	X
KAT2A	272	7	94.5	1	X	X
KAT2A	372	7	92.5	1	X	X
RBL1	964	7	93.2	5	-	X
RB1	608	6	80.4	2	-	X
RBL2	1035	6	92.1	8	X	-
WDR77	264	6	95.6	1	-	X
RB1	373	5	81.6	1	-	X
RBL2	401	5	63.2	1	X	-
VCP	664	5	92.5	1	-	X
FLCN	571	4	54.3	1	X	X
FOXM1	4	4	63.5	1	X	-
RB1	780	4	89.1	8	X	X
RBL1	369	4	74.6	4	-	X
SMAD3	8	3	82.1	2	X	-
VCP	509	4	80.3	2	-	X
TFEB	331	0	68.9	4	-	X
MEF2D	110	3	46.3	1	-	X
RB1	252	2	47.5	1	X	X
RB1	249	2	52.5	1	X	X
RB1	807	2	52.4	1	X	X
TFEB	142	3	53.4	1	X	X
TSC2	1217	2	53.3	1	X	-
RBL2	672	1	63.1	2	X	-
CDKN1A	98	0	42.1	21	-	X
RB1	811	2	43.6	2	X	X
RB1	795	1	52.7	6	-	X
CDKN1A	130	0	46.9	17	-	X
DNMT1	127	0	34.2	33	-	X
DNMT1	954	0	59.7	10	-	X
FLCN	73	0	30.3	10	X	X
FLCN	62	0	26.6	21	X	X
FLNA	2152	0	68.6	4	X	-
FOXM1	510	0	41.1	16	-	X
RB1	356	2	38.7	2	-	X
RB1	826	1	45.7	2	-	X
CDK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CTNNB1	191	9	96.4	1	-	X
TP53	20	8	64.0	0	X	-
CTNNB1	246	7	96.7	1	-	X
DBN1	142	7	49.9	1	X	X
AR	83	6	54.1	0	-	X
FBXO22	162	5	95.1	0	X	-
FZR1	163	4	79.5	1	-	X
PIK3C3	159	4	90.3	1	X	X
TP53	15	4	53.9	1	-	X
TPPP	160	4	84.4	1	-	X
PIK3C3	668	3	97.0	4	-	X
FBXO22	160	2	94.0	1	X	-
PARP1	786	2	78.8	0	X	-
PARP1	785	2	75.2	0	X	-
RB1	807	2	52.4	1	-	X
PARP1	782	0	71.8	3	X	-
CRMP1	509	0	69.2	21	X	X
STMN3	73	0	61.2	6	-	X
STMN3	68	2	58.2	1	-	X
ADD2	604	0	40.6	24	X	-
ADD2	617	0	36.8	37	X	-
ADD2	701	0	40.4	36	X	-
AMPH	285	0	41.5	38	-	X
AMPH	272	0	45.2	25	-	X
RB1	811	2	43.6	2	-	X
RB1	795	1	52.7	6	-	X
AMPH	276	0	43.0	29	-	X
AR	310	0	34.5	62	X	X
CDK5R1	138	0	48.9	10	X	X
CDK5R1	8	0	45.7	65	X	X
CDK6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FLNA	1459	8	79.1	1	X	-
RB1	821	6	40.3	1	-	X
RBL2	1035	6	92.1	8	X	-
RBL2	401	5	63.2	1	X	-
RB1	780	4	89.1	8	X	X
TFEB	142	3	53.4	1	X	X
RB1	252	2	47.5	1	X	X
RB1	249	2	52.5	1	X	X
RB1	807	2	52.4	1	X	X
RB1	811	2	43.6	2	X	X
TSC2	1217	2	53.3	1	X	-
PFKFB3	463	1	67.1	12	X	-
RB1	826	1	45.7	2	-	X
RB1	795	1	52.7	6	-	X
RBL2	672	1	63.1	2	X	-
TFEB	331	0	68.9	4	-	X
FLNA	2152	0	68.6	4	X	-
CDKN1B	187	0	66.4	90	-	X
CDKN1B	10	0	62.0	17	-	X
RB1	788	0	60.8	13	-	X
TFEB	467	0	54.2	17	-	X
FOXM1	522	0	44.9	4	-	X
FOXM1	510	0	41.1	16	-	X
FOXM1	611	0	41.0	65	-	X
FOXM1	508	0	39.2	18	-	X
FOXM1	627	0	40.9	81	-	X
FOXM1	704	0	34.9	16	-	X
FOXM1	489	0	39.1	37	-	X
CDK7s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK2	168	7	92.6	0	-	X
MCM2	108	6	76.9	0	-	X
CDK2	46	5	67.0	0	-	X
RB1	780	4	89.1	8	X	-
CDK2	165	3	79.4	2	-	X
MCM2	53	2	36.6	0	-	X
RB1	807	2	52.4	1	X	-
RB1	811	2	43.6	2	X	-
CDK2	160	1	36.8	2	-	X
E2F1	433	1	57.7	2	X	X
E2F1	403	0	52.6	5	X	X
MCM2	5	0	34.4	47	-	X
MCM2	41	0	36.8	11	X	X
MCM2	13	0	35.5	39	-	X
MCM2	4	0	34.7	48	-	X
RARG	79	0	64.9	12	-	X
RARG	77	0	62.9	14	-	X
TP53	392	0	48.5	35	-	X
TP53	378	0	42.5	21	-	X
TP53	371	0	41.8	14	-	X
SUPT5H	784	0	40.7	32	-	X
MCM2	59	0	35.3	6	-	X
TP53	33	0	35.6	8	-	X
MCM2	139	0	35.1	9	X	X
MCM2	40	0	37.1	12	-	X
CDK8s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CCNH	5	7	94.4	1	X	X
CCNH	304	0	31.5	8	X	X
NOTCH1	2513	0	28.5	34	X	X
NOTCH1	2511	0	27.6	36	X	X
NOTCH1	2516	0	29.9	31	X	-
SMAD1	195	0	41.3	20	-	X
SMAD1	187	0	38.9	12	-	X
SMAD1	206	0	37.5	31	X	X
SMAD1	214	0	36.8	39	-	X
SMAD3	179	0	37.0	15	X	X
SMAD3	213	0	40.7	8	-	X
SMAD3	208	0	41.9	13	-	X
CDK9s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RCHY1	217	10	84.8	0	X	X
ACTL6A	195	7	94.2	0	X	-
ACTL6A	86	5	97.4	1	X	-
RCHY1	211	5	92.5	0	X	X
ACTL6A	233	3	95.9	1	X	-
POLR2A	1525	3	61.7	1	-	X
RB1	807	2	52.4	1	-	X
RB1	811	2	43.6	2	-	X
RB1	795	1	52.7	6	-	X
CDK9	186	0	94.1	6	-	X
CDK9	353	0	33.9	14	-	X
CDK9	363	0	35.9	24	-	X
CDK9	362	0	35.9	23	-	X
CDK9	347	0	33.6	8	-	X
CDK9	354	0	34.8	15	-	X
POLR2A	1540	0	57.8	10	-	X
TP53	392	0	48.5	35	-	X
TP53	315	0	44.5	9	-	X
SMAD3	208	0	41.9	13	-	X
SMAD1	195	0	41.3	20	-	X
SUPT5H	814	0	39.0	6	X	X
SMAD3	213	0	40.7	8	-	X
TP53	33	0	35.6	8	X	X
NCOA2	487	0	32.8	111	X	-
NCOA2	493	0	34.6	117	X	-
NCOA2	499	0	35.3	123	X	-
NCOA2	469	0	32.9	93	X	-
POLR2A	1616	0	32.8	86	X	X
CDKL2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDKL5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDKL5	171	0	59.3	5	X	X
CDKL5	169	0	52.0	7	-	X
YLPM1	1089	0	32.0	16	X	-
YLPM1	1088	0	32.3	17	X	-
ChaK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PLCG2	1164	14	96.7	0	X	X
TRPM7	1685	11	88.0	0	-	X
MYH9	1808	10	61.0	0	-	X
MYH9	1800	10	58.0	0	-	X
TRPM7	1258	10	60.9	0	-	X
TRPM7	1583	10	88.2	0	-	X
ANXA1	5	9	79.5	0	-	X
MYH9	1803	9	57.4	0	-	X
TRPM7	1265	9	51.5	0	-	X
TRPM7	1255	9	65.7	0	-	X
TRPM7	1779	9	84.2	0	-	X
TRPM7	1191	8	82.4	0	-	X
TRPM7	1567	7	41.4	0	-	X
PLCG2	1045	6	85.8	1	X	-
TRPM7	1660	6	78.9	0	-	X
TRPM7	1695	3	85.6	0	-	X
TRPM7	1193	6	81.9	0	-	X
TRPM7	1163	4	81.8	1	-	X
TRPM7	1615	4	75.0	2	-	X
TMOD1	2	4	64.0	1	-	X
TMOD1	54	0	63.4	5	-	X
TRPM7	1569	5	38.2	0	-	X
TRPM7	1551	4	28.7	1	-	X
TRPM7	1598	6	59.9	1	-	X
TRPM7	1482	0	26.4	70	-	X
TRPM7	1860	4	43.7	1	-	X
TRPM7	1271	3	37.8	1	-	X
TRPM7	1830	4	58.0	1	-	X
ChaK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
H3C1	3	0	None	100000	-	X
H3C1	6	0	None	100000	-	X
Chk1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FANCE	346	12	91.8	0	X	X
PLK1	137	12	94.8	0	X	X
RPL19	12	12	96.2	0	-	X
CHEK1	382	10	84.2	0	X	X
CHEK1	378	10	84.4	0	X	X
CDC25A	507	9	64.1	0	X	X
MAD2L1	185	8	97.8	1	-	X
TP53	20	8	64.0	0	X	X
MAD2L1	187	7	97.5	0	-	X
SRC	419	7	66.8	0	-	X
TBC1D4	485	7	88.5	0	-	X
TP53	18	7	58.3	0	-	X
ZBTB11	511	7	41.1	0	-	X
CDC25B	563	6	71.8	0	-	X
MATR3	150	6	67.2	0	-	X
FANCE	374	5	95.8	0	X	X
RPL19	56	0	95.5	4	-	X
BLM	646	3	93.2	2	X	X
PLK1	210	2	87.6	2	X	X
SRC	530	4	83.0	3	-	X
TLK1	679	5	81.8	1	-	X
CHEK1	316	2	33.1	0	-	X
RBM14	618	3	47.5	0	-	X
ZBTB11	537	4	49.3	1	-	X
TICRR	865	3	49.7	13	-	X
BLM	539	0	30.4	28	-	X
BLM	182	0	32.7	24	X	X
BLM	502	0	29.2	65	X	X
CCDC6	244	0	39.9	9	-	X
CCDC6	240	0	39.0	5	-	X
CDC25A	76	0	39.9	25	X	X
TP53	15	4	53.9	1	X	X
LATS2	835	1	53.7	8	X	X
Chk2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CHEK2	379	11	59.1	0	X	X
CHEK2	225	10	87.3	0	-	X
CHEK2	383	8	64.6	0	X	X
H1-2	92	8	90.1	1	-	X
H1-2	55	8	94.1	0	-	X
TP53	20	8	64.0	0	X	X
AATF	477	7	62.6	0	-	X
CHEK2	260	7	50.5	1	-	X
H1-2	89	7	95.5	0	-	X
TP53	18	7	58.3	0	-	X
AATF	510	6	68.9	0	-	X
CHEK2	387	6	71.3	1	X	X
ELAVL1	118	6	91.7	1	X	X
ELAVL1	88	6	90.7	0	X	X
CHEK2	435	4	88.2	1	-	X
CHEK2	120	3	96.5	0	-	X
CHEK2	140	3	96.1	2	-	X
SIAH2	119	2	93.8	2	X	-
ELAVL1	100	3	86.4	1	X	X
CHEK2	432	2	86.3	1	-	X
H1-2	36	0	68.9	4	-	X
SIAH2	68	4	67.0	1	X	-
TP53	15	4	53.9	1	-	X
AATF	143	0	33.8	8	-	X
BECN1	93	0	34.6	16	X	X
BECN1	90	0	35.2	19	X	X
CDC25A	279	0	40.3	37	-	X
CDC25A	124	0	41.0	17	X	X
CK1A2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CK1As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EIF6	174	10	95.3	0	X	-
NR3C2	800	10	96.0	0	X	X
NR3C2	936	9	96.1	0	-	X
PHLPP1	1359	9	92.9	0	-	X
SNCA	87	9	70.0	0	-	X
EIF6	175	8	95.2	0	X	-
LGALS3	12	8	44.1	0	-	X
PHLPP1	1379	8	92.4	0	-	X
TP53	20	8	64.0	0	X	X
ATF1	51	7	48.7	0	X	-
TARDBP	242	7	78.3	0	-	X
TARDBP	254	7	80.3	0	-	X
TP53	18	7	58.3	0	X	-
ATF1	50	6	48.3	1	X	-
CREB1	100	6	60.5	0	X	X
PHLPP1	1381	6	94.4	1	-	X
DEPTOR	149	4	93.1	2	-	X
SLC4A1	303	6	89.1	1	-	X
TARDBP	116	6	88.9	1	-	X
PHLPP1	1363	4	87.2	1	-	X
OSBP2	762	6	83.9	0	-	X
TARDBP	25	6	82.6	1	-	X
TARDBP	4	5	81.0	0	-	X
PRKN	378	1	80.7	7	-	X
AGO2	834	5	48.0	0	X	X
AGO2	824	5	41.5	0	X	X
GJA1	325	6	51.5	0	-	X
OSBP2	763	3	77.2	0	-	X
LGALS3	6	4	52.6	1	-	X
TARDBP	2	2	80.0	2	-	X
AGO2	831	1	32.1	3	X	X
ATF1	47	2	46.6	1	X	-
ATF1	36	2	45.4	2	X	-
OSBP2	768	2	57.3	1	-	X
SNCA	129	2	52.2	2	X	X
TARDBP	183	4	49.5	1	-	X
CK1Ds, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NEDD9	780	15	93.8	0	-	X
FUS	338	11	91.3	0	-	X
FUS	346	9	90.2	0	-	X
TP53	20	8	64.0	0	-	X
TP53	18	7	58.3	0	-	X
NEDD9	804	5	93.3	0	-	X
TARDBP	333	5	47.8	0	X	-
FUS	273	4	44.3	0	-	X
MDM2	262	4	51.8	0	-	X
DCK	72	3	57.6	1	-	X
DCK	74	3	59.7	0	-	X
EPAS1	528	3	48.4	0	-	X
DCK	15	2	45.0	1	-	X
EPAS1	383	2	44.9	2	-	X
FUS	277	2	46.2	2	-	X
MDM2	279	0	63.9	13	-	X
MDM2	253	0	60.9	8	-	X
MDM2	290	1	53.7	2	-	X
MDM2	260	2	53.5	1	-	X
MDM2	269	0	53.2	4	-	X
MDM2	240	0	50.1	21	-	X
APC	1507	0	None	100000	-	X
APC	1510	0	None	100000	-	X
APC	1504	0	None	100000	-	X
APC	1505	0	None	100000	-	X
DCK	11	0	38.6	5	-	X
DVL2	143	0	30.9	53	X	X
DVL2	224	0	42.7	41	X	X
FUS	163	0	39.4	109	-	X
FUS	183	0	38.0	89	-	X
CK1Es, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TRAF3	349	9	84.6	0	X	X
DVL3	280	8	87.4	0	X	-
EIF4EBP1	41	8	87.3	1	X	X
TRAF3	116	8	95.4	0	X	-
DVL3	311	6	82.5	1	X	-
TRAF3	446	6	94.2	0	X	-
EIF4EBP1	50	5	81.8	2	X	X
CSNK1E	323	4	44.1	1	X	-
CSNK1E	368	4	38.0	1	X	-
CSNK1E	325	1	40.8	3	X	-
APC	1279	0	30.6	245	X	-
APC	1392	0	34.4	358	X	-
CSNK1E	407	0	32.8	24	X	-
CSNK1E	408	0	33.3	25	X	-
CSNK1E	405	0	32.8	22	X	-
SNAI1	107	0	61.4	11	-	X
SNAI1	104	0	60.2	14	-	X
TARDBP	409	0	47.7	76	X	X
TARDBP	410	0	46.2	77	X	X
TARDBP	404	0	44.0	71	X	X
CSNK1E	337	0	43.6	15	X	-
TARDBP	403	0	43.6	70	X	X
PER2	480	0	42.2	9	X	X
CSNK1E	334	0	42.9	12	X	-
DVL2	143	0	30.9	53	X	X
DVL2	224	0	42.7	41	X	X
CK1G1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
APC	1507	0	None	100000	-	X
APC	1505	0	None	100000	-	X
APC	1510	0	None	100000	-	X
APC	1504	0	None	100000	-	X
CK1G2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BECN1	406	6	78.2	0	X	-
BECN1	409	4	74.7	0	X	X
CK1G3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LRP6	1479	0	30.8	87	X	-
LRP6	1490	0	37.9	98	X	-
CK2A1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLC3A2	527	12	97.7	0	-	X
CALM3	82	10	70.1	0	X	X
AATF	288	9	91.7	0	-	X
ABCA1	1255	9	67.3	0	-	X
ATXN3	347	9	68.2	0	X	-
CALM3	80	9	64.8	0	X	X
DDIT3	31	9	77.2	0	-	X
DDIT3	30	9	82.7	0	-	X
DNAJB2	264	9	67.9	0	-	X
HTT	13	9	68.1	0	X	-
HTT	16	9	70.8	0	X	-
MYF5	133	9	97.0	0	-	X
NR3C2	111	9	74.4	0	X	X
PTGES3	118	9	62.8	0	X	X
RRAD	257	9	85.8	0	-	X
RRAD	214	5	98.5	1	-	X
SAT1	146	4	98.3	2	-	X
HHEX	163	4	98.2	1	-	X
HHEX	177	7	98.2	1	-	X
SAT1	149	5	97.8	0	-	X
DHFR	145	6	97.6	2	-	X
SLC3A2	531	9	97.4	0	-	X
TP53	155	7	97.0	1	-	X
TP53	149	2	96.8	3	-	X
TP53	150	1	96.7	4	-	X
TOP1	506	7	96.5	0	-	X
SRPK1	555	3	96.2	6	-	X
DHFR	168	3	96.1	3	-	X
AATF	155	6	45.8	0	-	X
ANP32A	158	2	71.7	0	-	X
ATF1	51	7	48.7	0	X	-
ATXN3	236	7	68.6	0	X	-
CAV2	36	4	57.6	0	X	X
CDH1	853	2	46.8	0	-	X
CERS4	349	6	55.1	0	X	-
CERS4	350	7	49.7	0	X	-
CERS5	350	4	63.1	0	X	-
CERS6	347	4	49.6	0	X	-
MYH9	1916	8	55.9	0	X	-
NCF1	283	8	94.6	0	-	X
RRN3	170	5	47.5	0	X	X
ABCA1	1242	8	78.9	1	-	X
CETN2	158	8	95.8	0	-	X
RIGI	855	7	77.5	0	X	X
CALM3	102	7	93.4	1	-	X
HSP90AB1	226	7	61.4	0	X	X
NCF1	208	7	94.8	0	-	X
RIGI	854	5	71.8	0	X	X
ABCA1	1243	7	78.4	1	-	X
RRN3	172	1	49.9	2	X	X
PPP1R2P3	127	6	66.7	0	-	X
PPP1R2P3	122	6	52.3	0	-	X
CERS6	346	5	32.5	0	X	-
CERS6	345	5	39.1	1	X	-
PPP1R2	122	4	53.2	1	-	X
PPP1R2P3	121	4	49.8	0	-	X
AMPH	387	3	41.4	2	X	X
CDH1	850	3	41.6	1	-	X
CERS4	342	3	77.5	1	X	-
CERS4	347	4	69.8	1	X	-
CK2A2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
XRCC1	488	7	72.5	0	X	-
CTNNB1	102	5	81.5	0	-	X
CTNNB1	29	4	33.8	1	-	X
SRPK1	555	3	96.2	6	-	X
XRCC1	485	3	54.5	1	X	-
SRPK1	51	1	57.4	8	-	X
XRCC1	518	1	47.1	3	X	-
CSNK2B	3	0	56.1	6	-	X
CSNK2B	2	0	50.7	7	-	X
CTNNB1	112	0	74.6	4	-	X
NKX3-1	93	0	43.7	40	X	X
NKX3-1	89	0	46.1	44	X	X
XRCC1	523	0	43.8	8	X	-
XRCC1	519	0	47.3	4	X	-
CK2Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CCDC106	147	0	46.0	32	X	X
CCDC106	130	0	55.6	21	X	X
SEC63	748	0	41.8	19	X	X
SEC63	574	0	34.7	19	X	X
SEC63	576	0	35.7	17	X	X
CLK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PTPN1	50	7	98.6	1	-	X
RBM17	266	6	76.7	1	X	X
PTPN1	243	5	92.5	0	-	X
PTPN1	242	5	91.8	0	-	X
RBM17	222	0	41.6	8	X	X
RBM17	288	0	51.2	7	X	X
RBM17	204	0	46.0	23	X	X
RBM17	62	0	45.5	24	X	X
RBM17	202	0	46.0	21	X	X
RBM17	291	0	53.6	4	X	X
RBM17	48	0	48.9	10	X	X
CLK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PTPN1	50	7	98.6	1	-	X
PTPN1	243	5	92.5	0	-	X
PTPN1	242	5	91.8	0	-	X
PAGE4	7	0	66.6	100000	-	X
PAGE4	73	0	70.5	100000	-	X
PAGE4	79	0	70.4	100000	-	X
PAGE4	71	0	71.9	100000	-	X
PAGE4	85	0	76.3	100000	-	X
PAGE4	94	0	65.4	100000	-	X
PAGE4	51	0	60.2	100000	-	X
PAGE4	9	0	66.2	100000	-	X
CLK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CLK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
COL4A3BPs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Cots, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PLK1	137	12	94.8	0	X	X
MAP2K1	222	9	67.2	0	X	X
MAP2K1	218	8	77.3	0	X	X
MAP2K2	222	8	79.5	0	X	X
MAP2K2	226	8	66.5	0	X	X
PLK1	210	2	87.6	2	-	X
IRF3	180	0	36.2	11	X	-
IRF3	175	0	36.7	16	X	-
IRF3	123	0	36.6	11	X	-
IRF3	188	0	61.8	3	X	-
IRF3	173	0	33.9	18	X	-
CRIKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MYL9	19	8	68.4	0	-	X
MYL9	20	6	65.5	0	-	X
CSFRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CSF1R	809	8	55.8	1	X	X
CSF1R	546	3	36.6	5	-	X
CSF1R	561	1	40.2	5	X	-
CSF1R	699	0	42.0	6	-	X
CSKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SRC	419	7	66.8	0	-	X
SRC	530	4	83.0	3	X	X
SRC	527	0	None	100000	X	X
CTKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SIRPA	453	0	41.4	50	X	-
SIRPA	429	0	44.6	26	X	-
DAPK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RIGI	764	14	95.2	0	-	X
TP53	269	10	97.6	0	-	X
RIGI	8	9	84.1	0	-	X
DAPK1	289	8	77.7	1	-	X
DAPK1	308	8	44.2	0	X	X
RIGI	654	8	92.3	0	-	X
TP53	20	8	64.0	0	X	X
TP53	18	7	58.3	0	-	X
RIGI	770	5	94.9	0	-	X
RIGI	674	4	57.6	1	-	X
RIGI	671	0	56.5	4	-	X
RIGI	667	0	50.0	6	-	X
DAPK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DAPK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DAPK3	306	12	82.9	0	-	X
DAPK3	225	10	89.7	0	-	X
DAPK3	299	9	87.1	1	-	X
MYL12B	19	8	68.8	0	X	X
MYL9	19	8	68.4	0	X	-
DAPK3	265	6	97.5	1	-	X
MYL12B	20	6	65.6	0	X	X
MYL9	20	6	65.5	0	X	-
DAPK3	311	5	65.0	0	-	X
PPP1R14A	38	5	63.0	0	-	X
DAPK3	180	3	77.4	1	-	X
MDM2	186	0	42.9	9	-	X
MDM2	166	0	44.1	29	-	X
PPP1R14A	12	0	45.8	25	-	X
DCAMKL1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DDR1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DDR1	586	4	61.7	1	-	X
DDR1	569	0	36.1	5	-	X
DLKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MYL12B	19	8	68.8	0	-	X
MYL12B	20	6	65.6	0	-	X
DMPK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DNAPKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NHEJ1	55	10	93.3	0	-	X
NHEJ1	223	10	94.7	0	-	X
NHEJ1	132	10	97.8	0	-	X
PRKAG1	284	10	95.8	0	X	X
PRKAG1	192	10	95.8	0	X	X
VIM	459	9	75.4	0	-	X
CHEK2	383	8	64.6	0	-	X
POU2F1	141	8	50.7	0	-	X
TP53	20	8	64.0	0	-	X
AIRE	68	7	91.6	0	-	X
AKT1	473	7	82.0	1	X	X
TP53	18	7	58.3	0	-	X
XPA	196	7	96.4	1	-	X
CHEK2	387	6	71.3	1	-	X
GOLPH3	148	6	97.9	1	X	X
GOLPH3	143	4	97.4	1	X	X
XPA	173	2	93.9	0	-	X
XRCC6	51	3	83.1	2	-	X
MAPKAP1	343	6	72.3	0	X	X
AKT1	308	2	72.1	2	X	-
POU2F1	143	6	45.1	0	-	X
XRCC5	580	5	41.0	0	-	X
XRCC6	33	1	63.2	4	X	-
AIRE	156	0	49.8	53	-	X
CHEK2	68	0	39.3	26	X	X
DCLRE1C	503	0	33.9	10	-	X
DCLRE1C	553	0	37.5	60	-	X
DCLRE1C	645	0	33.8	12	X	X
DCLRE1C	516	0	36.3	23	X	X
DCLRE1C	548	0	40.8	55	-	X
DCLRE1C	538	0	37.3	45	-	X
TP53	15	4	53.9	1	X	X
MCC	118	2	36.3	1	X	-
XRCC6	27	4	40.6	1	X	-
DRAK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DYRK1As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TRAF3	75	6	95.2	0	X	-
TRAF3	29	3	75.0	10	X	X
SF3B1	434	2	38.8	2	X	X
AMPH	295	0	42.2	48	-	X
AMPH	310	0	39.9	63	-	X
AMPH	293	0	43.0	46	X	X
AMPH	312	0	39.4	65	-	X
CCNL2	369	0	44.7	55	-	X
CCNL2	330	0	43.7	16	-	X
CCNL2	338	0	44.5	24	-	X
NFATC1	261	0	38.7	45	X	-
NFATC1	409	0	49.3	6	X	-
NFATC1	403	0	33.7	12	X	-
NFATC1	278	0	41.4	28	X	-
POLR2A	1616	0	32.8	86	X	X
RCAN1	167	0	70.0	4	-	X
RCAN1	247	0	68.0	15	-	X
TRAF3	9	0	30.9	30	X	-
POLR2A	1619	0	35.3	89	X	X
DYRK1Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NKX3-1	186	9	79.6	0	-	X
NKX3-1	185	9	84.1	0	-	X
DYRK1B	421	7	98.3	1	X	-
DYRK1B	273	1	92.8	4	X	X
DYRK1B	271	0	84.5	4	X	X
DYRK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EIF4EBP1	65	9	81.6	1	-	X
KATNA1	42	5	82.6	0	-	X
HSF1	326	4	52.5	1	X	X
SIAH2	68	4	67.0	1	X	-
SIAH2	119	2	93.8	2	X	-
CARHSP1	32	1	55.2	3	-	X
CDC25A	321	1	49.5	2	X	X
CARHSP1	41	0	72.7	5	-	X
CARHSP1	30	0	51.3	5	-	X
CDC25A	283	0	45.1	40	X	X
CDC25A	107	0	49.8	34	X	X
CDC25A	18	0	49.3	23	X	X
CDC25A	88	0	46.6	37	X	-
CDC25A	320	0	43.0	3	X	X
CDC25A	156	0	45.6	14	X	X
HSF1	363	0	46.2	13	-	X
HSF1	323	0	41.2	4	-	X
HSF1	320	0	34.1	7	X	X
SIAH2	28	0	44.6	10	X	X
EIF4EBP1	101	0	43.9	12	-	X
SIAH2	26	0	40.6	12	X	-
CDC25A	185	0	40.0	43	X	X
DYRK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DYRK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EEF2Ks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EEF2	57	8	74.8	0	X	X
EEF2K	500	6	94.9	2	-	X
EEF2K	366	1	38.7	5	-	X
EEF2K	348	1	82.8	3	X	X
EEF2	56	0	None	100000	-	X
EEF2	53	0	None	100000	-	X
EEF2	58	0	None	100000	-	X
EEF2K	396	0	32.0	35	X	-
EEF2K	78	0	48.3	3	-	X
EEF2K	441	0	30.6	36	-	X
EEF2K	353	0	86.4	5	-	X
EEF2K	445	0	30.1	32	X	X
EEF2K	474	0	50.4	3	-	X
EGFRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
IKBKE	153	15	96.8	0	X	-
CTNNB1	654	13	96.6	0	-	X
GNAI1	155	12	97.0	0	X	X
VAV2	172	12	80.9	0	-	X
CTNNB1	142	11	88.0	0	X	X
PTK2	194	11	89.0	0	X	X
USP8	810	11	95.6	0	-	X
VAV2	142	11	84.8	0	-	X
BECN1	233	9	98.4	0	X	X
BECN1	229	9	98.3	0	X	X
CCDC50	217	9	84.9	0	X	-
EZR	354	9	84.6	0	-	X
BECN1	352	8	88.7	2	X	X
GNAI1	320	8	95.0	0	X	X
GNAI1	154	8	97.2	0	X	X
GSTP1	8	8	98.5	0	X	X
GSTP1	199	8	98.4	0	X	X
SCD	55	7	96.7	2	X	X
TRIP13	206	8	96.1	0	X	-
EZR	146	6	94.9	0	-	X
GSTP1	4	8	94.1	1	X	X
IKBKE	179	7	90.0	0	X	-
EGFR	1016	7	58.2	0	X	X
EGFR	869	4	64.0	0	X	-
EGFR	1172	3	59.1	0	X	X
GPRC5A	350	4	56.5	0	X	-
GPRC5A	347	5	59.4	0	X	-
TRIP13	56	8	86.2	0	X	X
CCDC50	304	0	56.3	73	X	-
CCDC50	279	0	43.7	48	X	-
CCDC88A	1799	0	34.2	22	-	X
SCD	41	2	47.8	0	X	X
ENPP3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphA1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphA2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EPHA2	628	11	90.2	2	X	-
EPHA2	772	10	54.3	0	X	X
EPHA2	960	10	59.0	0	X	-
EPHA2	921	8	82.8	0	X	-
EPHA2	694	6	94.5	1	X	-
EPHA2	594	6	69.1	1	X	X
EPHA2	735	6	85.9	1	X	X
EPHA2	588	3	77.8	3	X	X
EPHA2	575	0	35.4	16	X	-
EphA4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EPHA4	602	6	78.6	1	-	X
EPHA4	596	3	82.7	3	-	X
EPHA4	779	0	29.3	3	-	X
EphA5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphA6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphA7s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphA8s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphB1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphB2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EphB3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ERK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RHOA	100	11	98.4	0	X	X
ARRB2	14	10	95.1	1	-	X
DUSP6	300	10	94.9	0	X	-
HNF4A	262	10	91.8	0	-	X
HNF4A	265	10	94.8	0	-	X
HNF4A	313	9	95.5	0	-	X
RHOA	88	9	98.5	0	X	X
CIC	1389	8	46.4	0	X	-
METTL3	525	7	94.5	1	X	-
NUP153	320	7	67.1	1	-	X
OSBP2	762	6	83.9	0	-	X
HNF4A	166	5	82.4	2	-	X
JUN	73	5	63.4	0	X	X
TOP2A	1213	5	83.7	1	-	X
XBP1	68	5	80.9	1	X	-
HNF4A	95	2	96.9	4	-	X
SPHK2	614	4	96.7	2	X	X
ARRB2	276	4	96.4	1	-	X
MAPK3	207	3	87.5	1	-	X
HNF4A	151	4	82.5	1	-	X
HNF4A	148	3	72.6	0	-	X
HNF4A	147	2	62.3	0	-	X
NUP153	257	4	50.5	0	-	X
OSBP2	763	3	77.2	0	-	X
ATF2	71	4	58.0	1	X	X
HSF1	326	4	52.5	1	X	-
MCRIP1	30	4	80.7	1	X	-
PCBP2	173	4	60.5	1	X	X
RUNX2	43	4	61.4	1	-	X
SP1	453	2	36.8	2	X	-
STMN1	25	1	77.0	2	-	X
ABI1	410	0	52.6	24	X	-
ABI1	183	0	53.7	28	X	-
ABI1	225	0	39.7	12	X	-
TP53	15	4	53.9	1	X	-
WTAP	148	4	76.9	1	X	-
XBP1	181	3	52.1	1	X	-
BANP	337	2	37.1	2	X	-
HNF4A	167	2	75.4	3	-	X
OSBP2	768	2	57.3	1	-	X
ERK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ARRB2	14	10	95.1	1	-	X
EIF4EBP1	65	9	81.6	1	-	X
RPS6KA3	529	9	91.4	0	-	X
CIC	1389	8	46.4	0	X	-
ERG	215	8	46.3	1	X	X
GLI1	102	8	64.1	1	-	X
RPS6KA3	488	8	86.3	0	-	X
CDKN1A	57	7	93.0	0	X	X
METTL3	525	7	94.5	1	X	-
NUP153	320	7	67.1	1	-	X
EIF4EBP1	37	6	87.4	1	-	X
JUN	73	5	63.4	0	X	X
KDM4B	352	5	86.6	1	X	-
MAPKAPK2	334	5	93.8	1	-	X
TOP2A	1213	5	83.7	1	-	X
PTPN7	93	4	97.1	1	-	X
SPHK2	614	4	96.7	2	X	X
ARRB2	276	4	96.4	1	-	X
DUSP1	296	2	92.3	2	X	X
EIF4EBP1	70	4	90.5	1	-	X
KDM4B	305	4	88.0	2	X	-
PTPN7	66	4	86.5	1	-	X
NUP153	257	4	50.5	0	-	X
CEP55	428	3	38.2	1	X	-
EIF4EBP1	46	4	85.0	1	-	X
MAPKAPK2	272	4	53.5	1	-	X
MCRIP1	30	4	80.7	1	X	X
NDEL1	245	4	78.4	1	-	X
PCBP2	173	4	60.5	1	X	X
TPPP	160	4	84.4	1	-	X
SP1	453	2	36.8	2	X	X
ABI1	410	0	52.6	24	X	-
ABI1	183	0	53.7	28	X	X
ABI1	225	0	39.7	12	X	X
ABI1	267	0	46.4	54	X	-
TP53	15	4	53.9	1	X	X
WTAP	148	4	76.9	1	X	-
BANP	337	2	37.1	2	X	-
KDM4B	622	2	66.1	1	X	-
MAFA	14	2	45.7	1	X	X
ERK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ERK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ERK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP2K5	149	9	49.0	0	-	X
MAPK7	28	7	42.9	0	-	X
MAPK7	774	6	36.3	0	X	-
MAP2K5	142	4	35.1	1	-	X
MAPK7	772	4	34.0	1	X	-
MAPK7	770	1	31.3	3	X	-
FOS	232	0	39.3	17	-	X
FOS	32	0	46.8	32	-	X
MAP2K5	129	0	36.4	8	-	X
MAP2K5	137	0	32.8	6	-	X
MAPK7	733	0	28.1	14	X	X
MAPK7	731	0	26.9	16	X	X
MAPK7	496	0	38.5	6	-	X
MAPK7	421	0	40.7	21	-	X
MAPK7	433	0	45.4	33	-	X
MEF2A	319	0	50.1	190	X	X
MEF2A	312	0	46.4	183	X	X
MEF2A	355	0	37.8	226	X	X
PML	409	0	37.8	13	-	X
PML	403	0	35.3	12	-	X
ERK7s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPK15	175	8	47.5	0	X	X
MAPK15	192	7	72.8	1	-	X
MAPK15	177	6	52.9	0	X	X
JUN	73	5	63.4	0	X	X
MAPK15	331	5	84.3	1	-	X
MAPK15	352	2	34.6	2	-	X
NFKBIA	36	2	67.6	0	X	X
NFKBIA	32	1	60.3	3	X	X
JUN	63	0	49.4	10	X	X
MAPK15	381	0	42.0	31	-	X
MAPK15	362	0	35.9	12	-	X
MAPK15	379	0	40.5	29	-	X
Etks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PTK2	194	11	89.0	0	-	X
PTK2	1007	10	86.1	0	-	X
PTK2	441	9	90.2	0	-	X
RUFY1	400	9	89.4	0	X	-
RUFY1	389	9	88.1	0	X	-
PTK2	925	8	87.3	0	-	X
TNK2	860	6	62.3	0	X	-
PTK2	577	5	61.6	0	X	X
TNK2	859	5	64.9	0	X	-
FGFR1	653	4	70.3	1	X	-
FGFR1	654	4	68.8	0	X	-
PTK2	576	4	64.2	1	-	X
PTK2	898	0	28.0	22	-	X
PTK2	742	0	32.1	39	-	X
PTK2	861	0	34.2	28	-	X
FAKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CLDN11	191	9	51.5	0	X	-
CLDN11	192	9	50.4	0	X	-
GRB7	338	9	94.5	0	X	-
ITGB7	753	9	88.2	0	-	X
ITGB7	758	9	83.8	0	-	X
GRB7	188	8	93.3	0	X	-
PTK2	397	7	70.0	1	X	X
PTK2	577	5	61.6	0	X	-
PTK2	576	4	64.2	1	X	X
PTK2	407	3	48.9	1	-	X
BCAR1	165	0	36.7	52	X	-
BCAR1	410	0	36.5	45	X	-
NANOG	35	0	52.9	69	X	X
NANOG	174	0	50.7	17	X	X
FAM20Cs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
VWF	1517	0	None	100000	-	X
VWF	1613	0	None	100000	-	X
Fers, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DPYSL2	479	9	96.8	0	X	X
EZR	354	9	84.6	0	X	-
FER	714	7	81.3	0	X	-
EZR	146	6	94.9	0	X	-
FER	615	5	93.8	1	X	-
DPYSL2	499	0	91.5	11	-	X
EZR	478	0	29.9	12	X	-
IRS4	921	0	37.7	50	X	-
IRS4	828	0	42.0	83	X	-
IRS4	847	0	30.6	102	X	-
IRS4	656	0	38.5	84	X	-
IRS4	779	0	46.3	34	X	-
Fess, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FES	811	13	98.2	0	X	X
FES	713	8	89.3	0	X	X
FGFR1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ZMYM2	502	10	73.2	0	X	-
LDHA	83	9	98.4	0	-	X
PDK1	136	9	94.6	0	X	X
FGFR1	730	8	95.3	0	-	X
FGFR1	154	8	93.3	0	-	X
ZMYM2	680	8	92.0	0	X	-
ZMYM2	683	8	92.3	0	X	-
ZMYM2	729	8	90.0	0	X	-
PDP1	94	7	97.3	0	X	X
PDK1	244	6	90.3	0	X	X
PDK1	243	6	82.1	0	X	X
ZMYM2	595	6	84.1	0	X	-
FGFR1	766	5	53.8	0	-	X
ZMYM2	557	5	68.0	1	X	-
ZMYM2	605	5	82.0	2	X	-
LDHA	10	3	92.2	2	X	X
PDP1	381	4	80.6	0	-	X
FGFR1	583	2	72.6	0	-	X
FGFR1	654	4	68.8	0	-	X
FGFR1	653	4	70.3	1	-	X
FGFR1	585	2	51.7	2	-	X
FGFR2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FGFR3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RPS6KA3	529	9	91.4	0	X	X
FGFR3	724	8	94.5	0	X	-
RPS6KA3	488	8	86.3	0	-	X
FGFR3	648	4	64.5	0	-	X
FGFR3	647	4	66.5	1	-	X
FGFR4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FGRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ALOX5	54	9	96.4	0	-	X
PTK2	925	8	87.3	0	X	-
PTK2	397	7	70.0	1	X	-
TBK1	354	7	98.2	0	X	-
ALOX5	446	4	98.2	1	-	X
PTK2	576	4	64.2	1	X	-
ALOX5	43	3	88.6	1	-	X
TBK1	394	3	97.6	12	X	-
FLT3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FLT3	842	9	79.0	1	-	X
FLT3	955	8	54.7	0	-	X
FLT3	591	7	71.7	0	-	X
FLT3	589	7	61.7	0	X	-
FLT3	599	2	87.6	2	X	-
FLT3	726	0	32.1	5	-	X
FLT3	969	0	32.2	11	-	X
FRKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
YAP1	407	0	42.9	22	X	-
YAP1	444	0	47.8	31	X	-
YAP1	391	0	40.5	6	X	-
Fyns, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ABL1	139	12	95.2	0	-	X
FYB1	559	11	91.6	0	-	X
FYB1	755	11	91.5	0	-	X
FYB1	757	11	91.8	0	-	X
JUP	133	11	89.5	0	-	X
SCN9A	1482	11	75.6	0	X	-
SKAP1	298	11	88.5	0	X	-
ABL1	128	10	94.8	0	-	X
SCN5A	1495	10	66.0	0	X	X
ABL1	115	9	94.8	0	-	X
ABL1	172	9	95.8	0	-	X
FYN	185	9	92.9	0	-	X
RPS6KA3	707	9	76.6	0	-	X
RPS6KA3	529	9	91.4	0	X	X
RPS6KA3	470	9	86.3	0	-	X
PPP2CA	284	6	97.4	0	X	-
ABL1	185	7	95.6	0	-	X
ABL1	70	6	93.4	2	-	X
ABL1	226	1	92.2	6	-	X
FYN	213	7	90.8	0	-	X
FYN	214	7	89.5	0	-	X
ABL1	215	4	88.7	0	-	X
CBL	731	4	35.0	0	X	X
CD5	453	2	43.4	0	-	X
DCBLD2	666	2	53.1	0	X	-
FYB1	571	5	76.5	0	X	X
SCN5A	1494	9	65.8	0	-	X
SCN9A	1481	9	75.7	0	X	-
PLXNA1	1679	8	73.6	0	X	-
PLXNA2	1677	8	71.1	0	X	-
PLEKHG1	661	6	60.1	0	X	X
RPS6KA3	483	8	85.3	0	-	X
RPS6KA3	488	8	86.3	0	-	X
GRIN2A	1105	4	29.9	0	-	X
FYN	420	6	60.2	0	X	X
RPS6KA3	580	3	50.7	1	-	X
CD3E	188	2	59.4	1	-	X
FYB1	771	2	60.4	1	-	X
JUP	550	4	77.1	1	-	X
PLEKHG1	742	2	51.1	0	X	X
PLXNA1	1608	2	37.9	0	X	-
G11s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GAKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TP63	281	3	86.5	0	-	X
TP63	46	0	28.6	6	-	X
GCKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GCN2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MARS1	662	9	97.9	0	X	X
MARS1	472	5	96.3	1	-	X
MARS1	229	4	89.3	1	-	X
GRK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GRK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ADIPOR1	205	11	96.1	0	X	-
ADRA1D	334	9	68.6	0	X	-
ADRA1D	332	9	62.9	0	X	-
ADRA1D	516	9	44.9	0	X	-
ADRA1D	518	9	45.4	0	X	-
OPRL1	346	9	69.6	0	X	-
OPRL1	351	9	79.8	0	X	-
OPRL1	362	8	70.5	0	X	-
OPRL1	363	7	66.4	0	X	-
EDNRA	391	4	37.9	0	X	-
EDNRA	393	3	32.9	2	X	-
GPBAR1	310	3	55.0	2	X	-
OPRD1	361	3	45.0	2	X	-
ADRA1D	323	2	46.2	2	X	-
NPFFR2	516	1	32.3	3	-	X
ADRA1D	300	0	42.9	3	X	-
OPRD1	363	0	42.2	4	X	-
GPBAR1	324	0	40.6	16	X	-
ADIPOR1	24	0	31.3	35	-	X
ADIPOR1	7	0	35.7	52	-	X
ADIPOR1	53	0	36.9	6	-	X
ADRB2	396	0	39.5	49	X	X
ADRB2	407	0	37.1	60	X	X
ADRB2	411	0	39.6	64	X	-
ADRB2	355	0	39.3	8	X	-
ADRB2	401	0	38.9	54	-	X
GRK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
OPRL1	346	9	69.6	0	X	-
OPRL1	351	9	79.8	0	X	-
OPRL1	362	8	70.5	0	X	-
OPRL1	363	7	66.4	0	X	-
SSTR2	343	7	50.9	0	X	-
SSTR2	341	6	48.5	1	X	-
OPRD1	361	3	45.0	2	X	-
ADRB2	355	0	39.3	8	X	X
ADRB2	356	0	39.0	9	X	X
CCR5	337	0	41.8	10	X	-
CCR5	342	0	41.6	15	X	-
CCR5	336	0	41.4	9	X	-
CCR5	349	0	41.5	22	X	-
OPRD1	363	0	42.2	4	X	-
GRK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BDKRB2	375	9	61.5	0	X	-
BDKRB2	373	9	58.2	0	X	-
GRK4	10	9	89.5	0	-	X
GRK4	419	9	98.5	0	-	X
GRK4	426	7	98.0	2	-	X
GRK4	249	7	96.3	2	-	X
GRK4	256	6	96.7	1	-	X
BDKRB2	366	5	47.3	0	X	-
GRK4	139	5	91.0	1	-	X
GRK4	244	5	96.5	1	-	X
GRK4	430	3	95.6	0	-	X
GRK4	485	0	84.7	5	-	X
GRK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GRK5	10	9	86.5	0	X	-
GPBAR1	310	3	55.0	2	X	-
ADRB2	396	0	39.5	49	-	X
ADRB2	407	0	37.1	60	-	X
ADRB2	411	0	39.6	64	-	X
ADRB2	355	0	39.3	8	X	X
ADRB2	393	0	37.4	46	-	X
ADRB2	401	0	38.9	54	-	X
ADRB2	356	0	39.0	9	X	X
ADRB2	384	0	34.1	37	-	X
GPBAR1	324	0	40.6	16	X	-
GPBAR1	323	0	39.3	15	X	-
GPBAR1	321	0	37.9	13	X	-
GRK5	485	0	85.9	6	-	X
GRK5	484	0	82.1	5	-	X
GRK6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CXCR4	324	9	58.9	0	X	-
CXCR4	325	9	56.5	0	X	-
ADRB2	355	0	39.3	8	X	X
ADRB2	356	0	39.0	9	X	X
GRK6	484	0	81.4	5	X	-
GRK6	485	0	85.0	6	X	-
SLC9A3R1	290	0	63.3	7	X	-
SLC9A3R1	289	0	None	100000	X	X
GRK7s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GRP78s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GSK3As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FBXL20	139	13	98.2	0	X	X
FBXL20	143	11	97.8	0	X	X
FBXL20	251	8	98.7	0	X	X
FBXL20	255	8	98.1	0	X	X
STAT2	385	8	94.0	0	X	X
CD274	279	7	52.7	0	X	X
OSBP2	762	6	83.9	0	-	X
STAT2	393	6	87.2	0	X	X
STAT3	714	5	72.8	0	X	-
STAT2	381	4	92.3	2	X	X
CD274	283	3	52.5	2	X	-
OSBP2	763	3	77.2	0	-	X
OSBP2	768	2	57.3	1	-	X
BCL3	402	0	47.6	40	X	-
BCL3	406	0	53.8	44	X	-
FBXL20	417	0	73.0	7	X	X
UNG	64	0	69.8	4	X	-
OSBP2	766	0	64.1	3	-	X
FBXL20	421	0	62.0	10	X	X
GRB14	423	0	38.7	3	X	X
CTNNB1	37	0	28.5	9	-	X
CTNNB1	33	0	29.4	5	-	X
CTNNB1	41	0	29.0	13	-	X
DES	32	0	43.5	60	X	-
DES	28	0	39.9	64	X	-
GSK3B iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GSK3Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FBXL20	139	13	98.2	0	X	X
DNM1L	44	11	90.0	0	X	X
FBXL20	143	11	97.8	0	X	X
HRAS	144	11	98.5	1	X	X
EIF4EBP1	65	9	81.6	1	-	X
EIF6	235	9	60.2	0	X	-
EIF6	239	9	66.0	0	X	-
PHLPP1	1359	9	92.9	0	X	X
PICK1	342	9	95.1	0	-	X
VDAC1	13	9	96.1	0	X	-
CD274	180	8	97.9	0	X	X
FBXL20	251	8	98.7	0	X	X
FBXL20	255	8	98.1	0	X	X
NFKB2	222	8	87.0	1	X	X
PHLPP1	1379	8	92.4	0	-	X
ENDOG	128	7	98.6	1	X	X
HRAS	148	5	97.4	0	X	X
SRC	493	6	96.2	0	X	-
PIAS1	17	6	94.6	0	-	X
PHLPP1	1381	6	94.4	1	-	X
STAT2	385	8	94.0	0	X	X
CD274	184	7	93.4	1	X	X
CDKN1A	57	7	93.0	0	-	X
DNM1L	40	7	88.8	0	X	X
DNM1L	693	5	85.0	0	X	X
EIF6	243	6	70.2	0	X	-
EIF6	231	7	52.0	0	X	-
GYS1	641	3	69.4	0	X	-
PSEN1	357	7	49.5	0	X	X
PIAS1	13	6	92.8	0	X	-
SNAI1	119	6	55.4	0	X	X
STAT2	393	6	87.2	0	X	X
OSBP2	762	6	83.9	0	-	X
STAT3	714	5	72.8	0	X	X
EIF4EBP1	37	6	87.4	1	X	X
STAT2	381	4	92.3	2	X	X
ENDOG	288	4	85.2	1	X	X
OSBP2	763	3	77.2	0	-	X
EIF4EBP1	46	4	85.0	1	X	X
SRC	419	7	66.8	0	X	X
VDAC1	107	6	90.7	0	X	-
PTTG1	184	7	62.0	0	X	X
GTF2F1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GTF2F1	385	0	43.5	15	-	X
GTF2F1	389	0	41.7	11	-	X
RARG	79	0	64.9	12	-	X
RARG	77	0	62.9	14	-	X
Haspins, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Hcks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ELMO1	216	13	93.5	0	X	X
ABL1	139	12	95.2	0	-	X
ELMO1	395	11	96.9	0	X	X
ABL1	128	10	94.8	0	-	X
ABL1	115	9	94.8	0	-	X
ABL1	172	9	95.8	0	-	X
ALOX5	54	9	96.4	0	-	X
ELMO1	511	9	95.8	0	X	X
ABL1	185	7	95.6	0	-	X
TBK1	354	7	98.2	0	X	-
ABL1	70	6	93.4	2	-	X
ALOX5	95	6	96.8	0	-	X
HCK	411	5	58.0	0	X	X
ABL1	215	4	88.7	0	-	X
HCK	522	4	84.4	4	-	X
TBK1	394	3	97.6	12	X	-
ABL1	226	1	92.2	6	-	X
ELMO1	18	3	89.5	2	X	X
ALOX5	43	3	88.6	1	-	X
ABL1	393	2	83.5	5	-	X
HER2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PLXNB1	1708	11	87.0	0	X	-
PLXNB1	1732	9	85.8	2	X	-
ERBB2	1023	5	62.7	0	-	X
ERBB2	877	3	60.5	0	X	-
ERBB2	1222	0	28.6	193	X	X
ERBB2	1112	0	29.4	83	-	X
ERBB2	1221	0	28.4	192	-	X
ERBB2	1248	0	48.6	219	X	X
ERBB2	1139	0	29.6	110	-	X
ERBB2	1196	0	33.8	167	X	-
HER4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ERBB4	1056	0	35.1	27	-	X
ERBB4	1162	0	28.1	8	-	X
ERBB4	1284	0	41.5	113	-	X
HGKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HTT	13	9	68.1	0	X	X
NR3C1	562	9	93.3	0	-	X
HTT	3	7	69.1	0	X	X
NR3C1	519	0	39.0	13	-	X
HIPK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MECP2	216	0	56.0	48	X	X
MECP2	80	0	56.9	7	-	X
HIPK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SIAH2	68	4	67.0	1	X	-
CEBPB	76	3	73.5	0	X	X
HIPK2	364	3	97.1	1	X	-
KLF3	250	3	49.4	1	X	X
HIPK2	361	2	80.2	2	X	-
HMGA1	78	2	64.4	1	-	X
SIAH2	119	2	93.8	2	X	-
ZBTB4	795	1	49.8	2	-	X
CEBPB	235	0	50.2	34	X	X
HIPK2	838	0	35.6	274	-	X
HIPK2	827	0	32.6	263	-	X
HIPK2	880	0	37.1	316	X	X
HIPK2	924	0	36.6	360	-	X
HIPK2	848	0	36.0	284	-	X
HIPK2	934	0	33.1	370	-	X
HMGA1	53	0	72.5	10	-	X
HMGA1	36	0	63.3	9	-	X
MECP2	80	0	56.9	7	-	X
MECP2	216	0	56.0	48	X	X
ZBTB4	983	0	53.0	52	-	X
PPM1D	54	0	50.6	23	-	X
ZBTB4	797	0	46.5	4	-	X
PML	38	0	30.2	9	X	X
SIAH2	28	0	44.6	10	X	X
PML	36	0	30.8	11	-	X
HIPK2	668	0	32.4	104	-	X
HIPK2	882	0	36.0	318	X	X
HIPK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HIPK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HPK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CARD11	558	0	34.6	12	-	X
CARD11	556	0	32.9	14	-	X
HRIs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HUNKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ICKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
IGF1Rs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PCNA	60	11	97.0	0	X	X
IGF1R	1165	9	53.5	1	X	X
IGF1R	1281	8	86.5	0	-	X
IGF1R	1280	8	89.9	0	-	X
IGF1R	1166	8	58.8	0	-	X
PCNA	250	8	96.7	0	X	X
IGF1R	982	6	49.9	1	-	X
PDPK1	376	5	49.3	0	X	X
PCNA	133	4	95.2	2	X	X
PDPK1	373	4	43.7	1	X	X
IGF1R	1161	3	44.4	1	X	X
IGF1R	980	3	40.1	0	-	X
IRS1	662	1	57.4	2	-	X
IRS1	989	0	38.0	329	-	X
IRS1	632	0	49.8	27	-	X
IRS1	896	0	51.7	236	-	X
IRS1	1179	0	49.0	519	-	X
SIRPA	496	0	46.9	93	X	X
IRS1	732	0	45.7	72	-	X
IRS4	921	0	37.7	50	X	-
IRS1	941	0	40.1	281	-	X
IKKAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MTOR	1418	12	82.2	0	-	X
MTOR	1415	10	85.2	0	X	X
NFKB2	108	8	89.5	0	-	X
CREBBP	1382	7	90.3	0	X	X
NFKB2	115	7	85.0	1	-	X
NFKB2	123	6	90.6	1	-	X
CREBBP	1386	4	93.3	2	X	X
COPS5	205	2	86.8	3	X	X
NFKBIA	36	2	67.6	0	X	X
NFKB2	99	1	92.4	2	-	X
NFKBIA	32	1	60.3	3	X	X
COPS5	201	0	69.9	7	X	X
CTNNB1	37	0	28.5	9	X	-
CTNNB1	45	0	30.6	17	X	-
CTNNB1	33	0	29.4	5	X	-
FOXA2	111	0	52.5	40	X	X
FOXA2	107	0	49.5	44	X	X
NFKB2	872	0	39.1	24	-	X
CTNNB1	41	0	29.0	13	X	-
MAP3K14	820	0	30.7	22	-	X
MAP3K14	817	0	30.7	19	-	X
MAP3K14	814	0	31.3	16	-	X
IKKBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
IRF3	405	10	87.7	0	X	-
HTT	16	9	70.8	0	X	X
HTT	13	9	68.1	0	X	X
IKBKG	68	9	94.2	0	-	X
IKBKG	85	9	96.8	0	-	X
RELA	311	9	83.2	0	-	X
RELA	131	9	92.7	0	-	X
IRF3	404	8	87.7	1	X	-
TSC1	487	8	62.1	0	X	X
HTT	3	7	69.1	0	X	-
IRF3	402	6	87.8	0	X	-
CYLD	568	5	82.6	2	-	X
EDC4	107	4	87.1	1	-	X
TP63	51	4	39.8	1	X	-
IKBKB	177	3	67.2	1	X	X
RELA	45	2	94.5	3	-	X
NFKB1	80	3	93.0	3	X	X
RELA	42	2	92.2	3	-	X
RELA	261	3	92.0	0	-	X
IRF3	396	3	88.5	0	X	-
IRF3	398	3	87.5	1	X	-
COPS5	205	2	86.8	3	X	X
NFKBIA	36	2	67.6	0	X	X
IKBKB	181	3	71.2	2	X	X
BCL10	138	0	49.1	19	X	X
CYLD	418	1	54.5	49	X	X
BCL10	136	0	49.6	17	X	X
BCL10	144	0	46.0	25	X	X
BCL10	141	0	47.6	22	X	X
BCL10	134	0	51.4	15	X	X
COPS5	201	0	69.9	7	X	X
CYLD	432	0	29.7	35	X	X
RELA	468	2	49.3	1	X	X
EDC4	405	1	78.0	4	-	X
NFKBIA	32	1	60.3	3	X	X
IKKEs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PELI1	80	13	85.8	0	-	X
PELI1	76	10	89.4	0	-	X
AKT1	473	7	82.0	1	X	X
IRF3	402	6	87.8	0	X	X
IRF3	386	5	84.4	2	X	X
IRF7	471	4	55.5	1	-	X
IRF3	398	3	87.5	1	-	X
IRF3	396	3	88.5	0	X	X
IRF7	472	3	52.8	2	-	X
NFATC1	161	3	50.8	1	X	X
PELI1	288	3	91.7	0	-	X
PELI1	293	3	87.1	1	-	X
AKT1	308	2	72.1	2	X	X
NFKBIA	36	2	67.6	0	X	-
RELA	468	2	49.3	1	X	X
NFKBIA	32	1	60.3	3	X	-
IRF1	215	0	54.3	20	X	X
IRF1	219	0	52.7	16	X	X
IRF1	221	0	51.8	14	X	X
IRF7	477	0	41.9	7	X	X
IRF7	479	0	41.8	6	X	X
ILKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MYL12B	19	8	68.8	0	-	X
MYL12B	20	6	65.6	0	X	X
INSRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PIK3R1	580	14	86.7	0	-	X
BLVRA	291	12	92.2	0	-	X
BLVRA	198	12	96.5	0	-	X
PTEN	174	11	98.3	0	-	X
BLVRA	228	10	95.6	0	-	X
PIK3R1	368	10	86.7	0	-	X
PTEN	27	10	96.2	0	-	X
PIK3R1	607	2	36.3	0	-	X
DOK1	362	0	60.7	5	-	X
DOK1	398	0	60.6	4	-	X
GAB1	242	0	40.9	54	-	X
GAB1	659	0	70.6	5	-	X
GAB1	373	0	40.9	148	-	X
GAB1	589	0	50.5	26	-	X
GAB1	447	0	49.3	74	-	X
GAB1	627	0	59.9	37	-	X
IRS1	896	0	51.7	236	-	X
IRS1	1179	0	49.0	519	-	X
GAB1	472	0	48.5	49	-	X
GAB1	285	0	41.2	97	-	X
IRAK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PELI1	86	15	83.8	0	-	X
PELI1	78	14	87.6	0	-	X
IRAK1	209	13	96.4	0	-	X
PELI1	80	13	85.8	0	-	X
PELI1	76	10	89.4	0	-	X
PELI1	82	8	83.7	0	-	X
PELI1	70	8	83.4	1	-	X
IRAK1	387	3	89.8	1	-	X
PELI1	288	3	91.7	0	-	X
PELI1	293	3	87.1	1	-	X
PELI1	127	2	47.5	1	-	X
PELI1	125	0	40.3	3	-	X
IRAK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PELI1	86	15	83.8	0	-	X
PELI1	78	14	87.6	0	-	X
PELI1	80	13	85.8	0	-	X
IRAK4	209	10	95.7	0	-	X
PELI1	76	10	89.4	0	-	X
PELI1	82	8	83.7	0	-	X
PELI1	70	8	83.4	1	-	X
IRAK4	352	7	85.7	0	-	X
IRAK4	208	7	94.7	0	-	X
IRAK4	8	6	91.6	0	-	X
NCF1	288	6	87.6	0	X	X
NCF1	138	5	85.9	1	-	X
IRAK4	6	4	89.1	1	-	X
NCF1	320	4	92.2	1	X	X
NCF1	370	4	73.7	1	-	X
PELI1	288	3	91.7	0	-	X
IRAK1	387	3	89.8	1	-	X
PELI1	293	3	87.1	1	-	X
IRAK4	346	2	76.0	6	X	X
IRAK1	376	2	59.4	2	-	X
IRAK4	345	3	74.8	7	X	X
IRAK4	342	2	73.9	8	X	X
PELI1	127	2	47.5	1	-	X
NCF1	133	1	66.1	2	X	X
IRE1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ITKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DEF6	210	13	94.8	0	X	-
DEF6	222	9	94.4	0	X	-
SIGLEC10	597	3	34.7	1	-	X
SIGLEC10	667	0	32.6	71	-	X
JAK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EIF2AK3	619	11	91.0	0	X	X
SIRT1	301	10	89.1	0	X	-
SNX8	95	10	93.2	0	X	-
SIRT1	280	9	75.8	0	X	-
SNX8	126	9	97.1	0	X	-
EIF2AK3	585	0	73.0	3	X	X
JAK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PAK1	285	14	94.7	0	X	X
GRB2	37	11	82.7	0	X	-
GRB2	209	9	92.1	0	X	-
GRB2	52	9	91.5	0	X	-
BRD4	97	8	94.5	0	X	X
STAP2	22	8	92.3	0	X	-
BRD4	98	7	90.5	0	X	X
PRMT5	297	7	86.5	0	X	X
SOCS3	221	7	75.9	0	X	-
GRB2	7	6	93.3	2	X	-
JAK2	119	6	94.2	2	X	-
PRMT5	307	6	95.6	1	X	X
PRMT5	304	6	93.3	1	X	X
STAP2	250	6	54.2	0	X	-
TET2	1964	6	65.1	0	X	X
JAK2	570	3	84.7	0	X	X
STAT5A	694	2	67.1	1	X	-
JAK2	523	2	39.5	0	X	X
PAK1	201	3	45.9	0	X	X
SOCS3	204	5	61.8	0	X	-
TET2	1939	4	65.0	1	X	X
PAK1	153	0	30.6	14	X	X
JAK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ELAVL1	63	11	93.6	0	-	X
ELAVL1	68	10	95.2	0	-	X
CTNNB1	86	9	68.0	0	X	X
JAK3	939	9	96.7	0	X	X
JAK3	980	7	93.6	0	X	X
JAK3	981	7	93.2	0	X	X
JAK3	785	6	63.1	0	X	X
JAK3	904	6	96.3	1	X	X
JAK1	1035	4	91.9	4	-	X
CTNNB1	30	3	32.8	2	X	X
JAK1	1034	3	92.0	3	-	X
SIGLEC10	597	3	34.7	1	-	X
ELAVL1	200	2	41.9	2	-	X
CTNNB1	64	0	29.5	12	X	X
SIGLEC10	667	0	32.6	71	-	X
SIGLEC10	691	0	37.9	95	-	X
JMJD6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
JNK1 iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
JNK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DIABLO	6	9	55.9	0	X	X
DIABLO	9	9	55.2	0	X	X
TP53	20	8	64.0	0	X	X
CDKN1A	57	7	93.0	0	-	X
NEIL1	61	7	98.1	0	-	X
ATF2	90	6	53.6	1	X	X
EEF1A2	358	6	95.1	2	-	X
HNRNPK	216	6	84.0	1	-	X
OSBP2	762	6	83.9	0	-	X
CDT1	491	5	87.3	1	X	-
EEF1A2	205	5	95.0	1	-	X
EIF4ENIF1	693	5	68.6	1	X	X
JUN	73	5	63.4	0	X	X
NFE2	346	5	87.1	1	X	X
NFE2L2	577	5	88.7	1	X	-
RARA	181	4	86.8	1	X	X
BCL2L1	115	4	83.6	1	X	-
OSBP2	763	3	77.2	0	-	X
BCL2	87	1	77.1	4	X	X
NEIL1	207	2	65.2	1	-	X
ATF2	71	4	58.0	1	X	X
ATF2	69	0	54.1	3	X	X
BCL2	70	0	46.5	21	X	X
BCL2	69	0	47.1	20	X	-
BCL2L1	62	0	47.8	21	X	X
NCOA3	24	2	40.2	1	-	X
NEIL1	306	2	33.9	1	-	X
OSBP2	768	2	57.3	1	-	X
JNK2 iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
JNK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TP53	20	8	64.0	0	X	X
CDKN1A	57	7	93.0	0	-	X
ATF2	90	6	53.6	1	-	X
JUN	73	5	63.4	0	-	X
ATF2	71	4	58.0	1	X	X
BCL2L1	115	4	83.6	1	-	X
ATF2	69	0	54.1	3	X	X
BCL2L1	62	0	47.8	21	-	X
BCL2L1	47	0	42.7	15	-	X
CDKN1A	98	0	42.1	21	-	X
CDKN1A	130	0	46.9	17	-	X
FOXO4	451	0	43.2	21	X	-
FOXO4	455	0	45.4	17	X	-
JUN	63	0	49.4	10	X	X
LIMD1	277	0	34.8	9	X	X
PDX1	61	0	52.5	59	-	X
LIMD1	272	0	51.4	4	X	X
PDX1	66	0	50.2	54	-	X
TOB1	154	0	49.6	19	-	X
TOB1	164	0	49.6	15	-	X
TOB1	152	0	48.7	17	-	X
TP53	46	0	39.3	3	-	X
NFATC4	213	0	38.4	5	-	X
PSEN1	319	0	34.2	8	X	X
NFATC4	217	0	39.6	9	-	X
PSEN1	320	0	34.0	9	X	X
JNK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
OSBP2	762	6	83.9	0	-	X
OSBP2	763	3	77.2	0	-	X
OSBP2	768	2	57.3	1	-	X
CDKN1A	98	0	42.1	21	-	X
CDKN1A	130	0	46.9	17	-	X
MYC	73	0	None	100000	-	X
MYC	86	0	None	100000	-	X
MYC	77	0	None	100000	-	X
OSBP2	766	0	64.1	3	-	X
KHKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KHS1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KHS2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ACE2	776	4	47.5	1	X	X
ACE2	783	0	37.3	8	X	X
KISs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NCOA3	1062	6	77.7	0	X	X
NCOA3	1067	6	77.8	0	X	X
SF1	80	1	68.6	2	X	X
SF1	82	1	74.1	4	X	X
Kits, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KIT	936	9	72.0	0	-	X
KIT	568	8	62.1	1	-	X
KIT	823	8	67.8	1	-	X
KIT	547	7	71.3	0	-	X
SLA	120	7	91.7	0	X	-
KIT	703	5	38.9	1	-	X
KIT	570	5	64.6	3	-	X
LAT2	118	5	67.3	0	X	-
KIT	553	4	60.0	4	-	X
KIT	721	0	45.0	15	-	X
LAT2	110	0	70.8	6	X	-
SLA	273	0	52.8	33	X	-
SLA	258	0	41.4	18	X	-
KSR2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KSRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LATS1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LATS1	909	8	50.6	0	-	X
YAP1	61	7	69.4	0	X	-
LATS1	674	5	80.1	1	-	X
LATS1	1049	3	55.8	1	-	X
KIF23	814	0	48.1	7	X	X
KIF23	716	0	28.2	6	X	X
YAP1	381	0	38.2	3	X	-
YAP1	109	0	46.7	13	X	-
YAP1	127	0	41.9	31	X	X
YAP1	164	0	49.0	5	X	-
LATS2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KIF23	814	0	48.1	7	-	X
KIF23	716	0	28.2	6	X	-
Lcks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SSBP3	25	12	95.1	0	X	-
VAV1	174	12	88.0	0	-	X
ZAP70	474	12	96.5	0	-	X
PTEN	240	11	97.0	0	X	-
SSBP3	23	11	93.8	0	X	-
ZAP70	126	11	89.9	0	-	X
PLCG2	1197	10	70.7	0	-	X
PTEN	315	10	84.5	0	X	-
THEMIS	540	10	83.3	0	X	X
THEMIS	95	10	91.9	0	-	X
THEMIS	353	10	82.1	0	-	X
VAV1	142	10	85.4	0	-	X
CCDC50	217	9	84.9	0	X	-
PLCG2	1217	9	71.2	0	-	X
THEMIS	541	9	76.6	0	X	X
TBK1	354	7	98.2	0	X	-
ACP1	132	2	98.0	0	X	-
ACP1	133	2	97.8	0	X	-
TBK1	394	3	97.6	12	X	-
ZAP70	315	7	95.9	1	-	X
ZAP70	178	7	95.0	0	-	X
THEMIS	174	7	91.6	0	-	X
ZAP70	319	5	91.6	0	X	X
ZAP70	69	7	90.4	0	-	X
BTLA	257	8	70.0	0	-	X
BTLA	282	6	68.3	0	-	X
CBL	731	4	35.0	0	X	-
CD5	453	2	43.4	0	X	X
LCK	394	5	56.9	0	X	X
SH2D2A	290	4	58.1	0	-	X
SOCS3	221	7	75.9	0	-	X
SOCS3	204	5	61.8	0	-	X
LCK	505	3	80.1	4	X	X
THEMIS	429	7	79.3	0	-	X
ZAP70	292	4	56.2	17	-	X
VAV1	160	6	71.9	0	-	X
PTPN6	536	6	40.1	1	-	X
LIMK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LIMK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LKB1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PRMT5	139	10	96.6	0	X	X
PRMT5	132	8	96.7	0	-	X
STK11	189	8	97.3	1	-	X
STK11	185	7	96.2	1	-	X
STK11	336	7	92.5	0	-	X
PRMT5	144	5	94.3	0	X	X
SIRT1	669	4	39.2	1	X	X
TP53	15	4	53.9	1	X	X
MARK3	215	3	86.1	1	-	X
SIRT1	615	3	33.4	2	X	X
MARK3	211	1	78.7	2	X	X
STRADA	419	1	36.2	4	-	X
PTEN	380	0	30.9	7	X	X
PTEN	383	0	32.4	4	X	X
PTEN	382	0	31.2	5	X	X
TP53	392	0	48.5	35	X	X
STK11	428	0	45.5	76	-	X
STRADA	329	0	38.9	14	-	X
SIRT1	732	0	37.8	64	X	X
STK11	402	0	36.8	50	-	X
STK11	363	0	34.4	11	-	X
Lmr1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Lmr2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PPP1CA	320	1	65.4	3	X	-
LOKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LRRK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK5RAP2	102	9	78.0	0	-	X
CDK5RAP2	140	9	67.2	0	-	X
NDEL1	155	9	97.3	0	X	X
NDEL1	166	9	96.6	0	-	X
NDEL1	162	9	97.0	0	-	X
NDEL1	132	9	98.6	0	-	X
NDEL1	95	9	98.6	0	-	X
NDEL1	213	0	44.4	23	-	X
LRRK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LRRK2	424	12	86.8	0	-	X
LRRK2	1404	11	73.9	0	-	X
LRRK2	1403	11	75.5	0	-	X
LRRK2	1485	10	88.8	0	-	X
LRRK2	1503	10	87.8	0	X	X
LRRK2	1332	10	77.1	0	-	X
LRRK2	1508	10	84.6	0	-	X
LRRK2	1402	9	74.1	0	-	X
LRRK2	1457	9	85.4	1	-	X
LRRK2	776	9	76.8	0	-	X
LRRK2	1452	9	87.2	0	-	X
LRRK2	1467	9	84.3	0	-	X
LRRK2	1445	9	80.7	1	-	X
LRRK2	1647	9	74.9	0	-	X
LRRK2	1536	9	85.9	0	-	X
RPS11	46	4	93.6	2	-	X
LRRK2	1969	8	90.9	0	-	X
LRRK2	1253	8	89.1	0	-	X
LRRK2	1967	7	87.4	1	-	X
LRRK2	1345	8	86.2	1	-	X
LRRK2	1853	8	85.6	0	-	X
LRRK2	1491	3	84.9	4	-	X
LRRK2	1849	8	84.9	0	-	X
LRRK2	1292	7	80.7	0	X	X
LRRK2	838	8	70.4	0	-	X
LRRK2	1443	7	77.3	0	-	X
LRRK2	1470	8	80.9	0	-	X
LRRK2	1343	3	78.4	0	-	X
LRRK2	1913	8	70.9	0	-	X
LRRK2	1444	5	77.6	0	-	X
LRRK2	1348	7	79.6	0	-	X
LRRK2	2524	7	64.0	0	-	X
LRRK2	524	6	62.0	0	-	X
LRRK2	1368	5	70.2	3	-	X
LRRK2	1410	5	80.1	2	X	X
LRRK2	1124	2	82.1	2	-	X
LTKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LYNs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ACLY	659	14	98.6	0	X	X
IRF5	335	14	97.4	0	X	-
ACLY	131	13	96.7	0	X	X
LY96	131	13	91.0	0	X	-
ABL1	139	12	95.2	0	-	X
RGS16	168	12	98.0	0	-	X
RGS16	177	11	96.4	0	-	X
ABL1	128	10	94.8	0	-	X
ACLY	384	10	95.8	0	X	X
AKAP8	539	10	81.0	0	X	-
IRF5	313	10	88.1	0	X	-
ABL1	115	9	94.8	0	-	X
ABL1	172	9	95.8	0	-	X
ACLY	682	9	98.5	0	X	X
ACLY	252	9	96.1	0	X	X
ABL1	185	7	95.6	0	-	X
ACLY	227	8	95.4	0	X	X
SYK	348	7	95.4	1	-	X
ABL1	215	4	88.7	0	-	X
AKAP8	436	9	84.4	0	X	-
BTK	551	8	76.3	0	X	-
CASP8	448	9	93.5	0	X	-
CSF2RB	466	9	81.1	0	-	X
SLC4A1	8	9	62.0	0	-	X
CSF2RB	468	9	78.8	0	-	X
IKBKB	188	7	92.3	0	X	-
LY96	22	6	94.2	0	X	-
CSF2RB	822	6	47.5	0	-	X
YY1	383	6	89.4	0	X	X
LYN	508	3	79.9	4	X	-
ABL1	393	2	83.5	5	-	X
PTPN6	536	6	40.1	1	X	X
SLC4A1	359	5	36.5	0	X	X
CD19	500	4	47.7	0	X	X
GCSAM	107	4	63.3	1	X	X
GCSAM	106	3	61.8	1	-	X
SYK	352	3	86.8	0	-	X
SYK	525	7	49.4	0	-	X
YY1	254	6	41.6	0	X	-
ABL1	70	6	93.4	2	-	X
LZKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAK	157	0	46.9	6	X	X
MAK	159	0	52.9	5	X	X
MAPKAPK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PLK1	383	10	95.3	0	-	X
HSPB1	78	9	52.2	0	X	X
HSPB1	82	8	60.4	0	X	X
NELFE	251	3	53.1	1	-	X
RBM7	136	2	48.9	2	X	X
PLK1	326	1	58.2	6	X	X
RCSD1	179	1	60.2	3	-	X
CDC25B	169	0	36.4	13	-	X
CDC25B	323	0	44.0	30	-	X
CDC25B	375	0	72.7	3	-	X
CDC25B	353	0	47.6	25	-	X
CEP131	47	0	29.8	211	-	X
CEP131	78	0	32.5	180	-	X
GJA1	255	0	38.9	12	-	X
GJA1	279	0	43.9	16	-	X
ZFP36L1	54	0	55.0	35	X	X
RCSD1	244	0	50.6	68	-	X
NELFE	51	0	50.4	7	-	X
ZFP36L1	203	0	50.4	11	X	X
ZFP36L1	92	0	49.2	20	X	X
RBM7	204	0	46.1	50	X	X
HSPB1	15	0	40.7	3	X	X
GJA1	282	0	45.7	13	-	X
MDM2	157	0	44.0	38	-	X
MDM2	166	0	44.1	29	-	X
MRTFA	333	0	34.6	19	X	X
MAPKAPK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPKAPK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DNAJB1	171	6	97.6	1	X	X
SEPTIN8	192	6	92.2	1	-	X
SEPTIN8	163	4	92.5	3	-	X
DNAJB1	151	0	46.7	14	X	X
DNAJB1	149	0	44.9	16	X	X
MARK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MARK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ARHGEF2	186	0	37.0	7	X	X
ARHGEF2	885	0	None	100000	X	X
ARHGEF2	143	0	40.5	41	X	X
ARHGEF2	959	0	None	100000	-	X
ARHGEF2	172	0	39.6	21	X	X
HDAC4	467	0	35.0	7	-	X
HDAC4	246	0	39.0	55	X	X
KIF13B	1410	0	27.0	37	X	X
KIF13B	1381	0	29.9	8	X	X
PARD3	873	0	36.0	18	X	-
PARD3	144	0	41.6	12	X	-
MARK3 iso3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MARK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MARK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAST3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAST4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MASTLs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MEK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MACC1	793	10	89.6	0	X	-
MACC1	695	9	86.5	0	X	-
MACC1	673	7	86.7	1	X	-
MAPK3	210	7	94.9	0	-	X
TARDBP	155	6	78.8	0	X	-
XRCC6	77	6	83.8	0	-	X
XRCC6	78	6	83.6	1	-	X
TARDBP	153	5	83.9	1	X	-
MAPK3	207	3	87.5	1	-	X
MAPK3	202	3	68.3	1	X	X
MAPK3	204	1	73.5	3	X	X
MAPK1	185	0	44.3	7	X	X
MAPK1	187	0	55.1	5	X	X
MEK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPK3	202	3	68.3	1	X	X
MAPK3	204	1	73.5	3	X	X
MEK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPK7	219	4	58.0	1	X	X
MAPK7	221	1	64.3	3	X	X
MEKK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP2K7	271	10	45.4	0	X	-
MAP2K7	275	5	44.9	0	X	-
MAFA	14	2	45.7	1	X	-
MAFA	65	0	49.9	37	X	-
MEKK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MEKK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GLI1	243	4	85.1	2	X	-
RCAN1	163	4	63.9	1	X	-
GLI1	201	0	40.1	35	X	-
GLI1	1074	0	41.3	14	X	-
GLI1	1078	0	45.4	10	X	-
GLI1	968	0	35.1	55	X	-
GLI1	204	0	40.9	32	X	-
RCAN1	167	0	70.0	4	X	-
MEKK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MEKK6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPK14	180	0	57.0	4	X	-
MAPK14	182	0	56.1	5	X	-
MAPK8	185	0	50.8	5	X	-
MAPK8	183	0	34.9	6	X	-
MELKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MELK	56	10	84.6	0	-	X
MELK	539	7	65.3	2	-	X
MELK	253	6	97.4	1	-	X
EIF4B	406	4	42.3	0	X	X
MELK	171	3	72.8	1	-	X
MELK	167	2	65.9	5	X	X
MELK	163	2	65.0	1	-	X
CDC25B	169	0	36.4	13	X	X
CDC25B	323	0	44.0	30	-	X
EIF4B	422	0	41.7	10	-	X
MELK	387	0	31.6	60	X	-
MELK	494	0	28.0	43	X	X
MELK	431	0	30.9	104	X	X
MELK	398	0	27.6	71	X	X
MELK	405	0	28.9	78	X	-
MELK	336	0	52.0	9	-	X
MELK	409	0	30.7	82	X	-
MELK	343	0	30.2	16	X	X
MELK	529	0	29.6	8	X	X
MELK	356	0	27.0	29	X	X
MELK	505	0	27.1	32	X	X
MELK	438	0	28.0	99	X	-
Mers, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AKT1	473	7	82.0	1	X	-
MERTK	754	4	68.2	0	X	X
MERTK	753	4	73.7	1	X	X
AKT1	308	2	72.1	2	X	-
MERTK	749	2	62.5	2	X	X
Mets, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PTK2	194	11	89.0	0	X	X
PTK2	925	8	87.3	0	X	X
PTK2	397	7	70.0	1	X	X
PTK2	577	5	61.6	0	X	X
PTK2	576	4	64.2	1	X	X
MET	1230	3	52.6	0	-	X
PTK2	407	3	48.9	1	X	X
MET	1365	2	83.2	6	-	X
MET	1356	2	62.0	13	-	X
MST1R	1353	1	61.0	6	X	-
MST1R	1239	1	49.1	6	X	-
IRS1	612	0	50.2	47	X	X
IRS1	896	0	51.7	236	X	X
MET	1349	0	58.4	6	-	X
MET	1234	0	53.5	3	X	X
MET	1235	0	56.4	3	X	X
MST1R	1238	0	48.0	6	X	-
MST1R	1360	0	35.1	13	X	-
MINKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NR3C1	562	9	93.3	0	-	X
NR3C1	635	8	91.4	0	-	X
NR3C1	524	0	42.6	8	-	X
MKK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP2K3	218	9	64.0	0	-	X
MAP2K3	222	6	54.9	0	-	X
MAPK13	180	3	42.6	2	X	-
MAPK13	182	0	60.5	4	X	-
MAPK14	180	0	57.0	4	X	X
MAPK14	182	0	56.1	5	X	X
MKK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP2K4	257	9	67.2	0	-	X
MAP2K4	261	5	61.6	0	-	X
MAPK10	223	0	41.9	5	X	-
MAPK14	180	0	57.0	4	X	X
MAPK14	182	0	56.1	5	X	X
MKK6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP2K6	207	9	62.1	0	X	-
MAP2K6	219	6	91.0	0	-	X
MAPK13	180	3	42.6	2	X	-
MAPK12	185	0	52.2	5	-	X
MAPK12	183	0	40.1	4	-	X
MAPK13	182	0	60.5	4	X	-
MAPK14	180	0	57.0	4	X	X
MAPK14	182	0	56.1	5	X	X
MKK7s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPK8	185	0	50.8	5	X	X
MAPK8	183	0	34.9	6	X	X
MAPK9	183	0	43.7	6	X	X
MAPK9	407	0	30.7	37	-	X
MAPK9	404	0	29.6	34	-	X
MLK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DYRK2	449	10	97.8	1	-	X
TCF3	341	3	57.0	2	X	X
DYRK2	381	2	95.2	5	-	X
TCF3	379	0	39.8	8	X	X
TCF3	355	0	40.0	16	X	X
TCF3	359	0	39.6	20	X	X
TCF3	352	0	40.4	13	X	X
MLK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP2K3	218	9	64.0	0	X	-
MAP2K4	257	9	67.2	0	X	X
PAK1	133	9	63.8	0	X	X
MAP2K3	222	6	54.9	0	X	-
MAP3K11	277	6	44.4	0	-	X
MAP3K11	281	6	50.4	1	-	X
GLI1	394	5	56.1	0	X	X
MAP2K4	261	5	61.6	0	X	X
GLI1	1089	3	34.5	0	X	X
PAK1	204	2	34.6	2	X	X
MLK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MLKLs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Mnk1 iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Mnk1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HNRNPA1	192	8	61.8	0	-	X
SFPQ	283	7	74.5	0	-	X
HNRNPA1	364	0	50.4	169	-	X
HNRNPA1	363	0	49.0	168	-	X
HNRNPA1	362	0	48.0	167	-	X
SFPQ	8	0	44.9	266	-	X
SPRY2	112	0	45.4	56	X	X
SPRY2	121	0	44.6	47	X	X
Mnk2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SFPQ	283	7	74.5	0	-	X
SFPQ	8	0	44.9	266	-	X
SPRY2	112	0	45.4	56	X	-
SPRY2	121	0	44.6	47	X	-
MOSs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
VIM	459	9	75.4	0	-	X
VIM	458	8	77.6	0	-	X
MPSK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
STK16	185	9	97.5	0	-	X
STK16	197	8	96.4	0	-	X
STK16	198	7	97.7	0	X	X
MRCKAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDC42BPA	403	11	94.5	1	-	X
CDC42BPA	234	5	81.1	1	-	X
CDC42BPA	240	3	89.6	1	-	X
CDC42BPA	1003	0	31.7	8	-	X
MRCKBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SIAH2	279	7	97.1	1	X	-
SIAH2	6	0	50.9	32	X	-
MSK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RPS6KA5	381	5	35.1	0	X	X
RPS6KA5	750	4	39.9	1	X	X
RPS6KA5	376	3	29.8	1	X	X
RPS6KA5	752	2	36.6	3	X	X
H3C1	10	0	None	100000	X	X
H3C1	28	0	None	100000	X	X
RPS6KA5	212	0	26.4	5	X	X
RPS6KA5	758	0	33.9	9	X	X
MSK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MST1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MOB1B	35	12	78.3	0	-	X
PRDX1	18	12	98.6	0	-	X
FOXO1	212	10	94.4	0	-	X
FOXO3	209	10	94.2	0	X	X
NR3C1	668	10	97.8	0	-	X
NR3C1	562	9	93.3	0	-	X
TNNI3	129	9	91.9	0	X	X
TNNI3	51	9	96.7	0	X	X
FOXO1	218	8	95.9	0	-	X
FOXO3	215	8	95.5	0	-	X
IRF3	75	8	80.4	0	X	X
FOXO3	232	7	90.0	1	-	X
NR3C1	682	7	96.6	0	-	X
PRDX1	90	7	97.5	1	-	X
FOXO3	243	5	65.3	1	-	X
PRDX1	183	3	97.6	1	-	X
FOXO1	235	4	90.3	2	-	X
NR3C1	746	3	89.8	2	-	X
IRF3	253	5	73.1	0	X	X
FOXO3	231	5	89.3	1	-	X
FOXO1	234	3	89.7	2	-	X
MOB1B	12	0	43.6	10	-	X
TNNI3	31	4	52.4	1	X	X
STK4	183	3	43.1	1	X	X
MST2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MOB1A	35	12	77.5	0	-	X
MOB1B	35	12	78.3	0	X	X
NR3C1	668	10	97.8	0	-	X
NEK2	356	9	83.0	0	-	X
NR3C1	562	9	93.3	0	-	X
PRKCA	226	9	98.4	0	-	X
LATS1	909	8	50.6	0	-	X
LATS1	1079	8	71.1	1	-	X
MOB1A	74	8	87.5	0	-	X
MOB1B	74	8	92.6	0	-	X
NEK2	406	8	51.4	0	-	X
NEK2	365	8	68.1	0	-	X
PRKCA	228	8	97.6	0	-	X
NR3C1	682	7	96.6	0	-	X
LATS1	967	5	93.4	0	-	X
LATS1	1012	4	94.2	0	-	X
NR3C1	746	3	89.8	2	-	X
STK3	378	1	68.3	14	-	X
LATS1	1060	5	51.0	0	-	X
LATS1	872	4	56.2	0	-	X
NEK2	438	5	44.6	0	X	X
SAV1	36	5	45.7	0	X	-
MOB1A	12	1	53.7	9	-	X
MOB1B	12	0	43.6	10	X	X
STK3	180	4	43.5	1	X	-
MST3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MST4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDCD10	43	9	97.2	0	X	-
PDCD10	39	7	97.2	0	X	-
YAP1	94	4	81.0	0	-	X
YAP1	77	4	66.1	0	-	X
YAP1	83	0	70.9	3	X	X
YAP1	41	0	48.2	10	-	X
YAP1	110	0	45.4	14	-	X
mTORs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AKT1S1	221	9	87.8	0	X	-
DUSP10	224	9	58.2	0	-	X
EIF4EBP1	65	9	81.6	1	X	X
RPS6	236	9	77.8	0	X	-
RPS6	235	9	80.0	0	X	-
EIF4EBP1	41	8	87.3	1	X	-
PRKCE	729	8	92.4	1	X	-
RPS6KB1	412	8	82.9	1	X	X
AKT1	473	7	82.0	1	X	X
PIP4K2C	328	7	72.4	1	X	-
EIF4EBP1	44	6	84.9	0	X	-
EIF4EBP1	37	6	87.4	1	X	X
MAF1	60	6	90.7	3	X	X
SENP3	139	6	55.0	0	X	X
DUSP10	230	5	75.2	0	-	X
EIF4EBP1	70	4	90.5	1	X	X
PRKCE	710	0	86.8	4	X	-
EIF4EBP1	46	4	85.0	1	X	X
RPS6KB1	394	0	84.1	6	X	X
PRKCE	566	2	78.5	2	X	-
GRB10	428	5	51.4	0	-	X
PASK	949	5	35.1	0	-	X
ULK1	638	4	41.4	0	X	-
HSF1	326	4	52.5	1	X	X
SENP3	141	4	47.9	1	X	X
SENP3	142	3	51.6	2	X	X
AKT1	450	0	50.5	4	-	X
AKT1S1	183	0	66.7	32	X	X
ANKRD17	2047	0	24.3	149	X	-
ANKRD17	2045	0	24.6	147	X	-
APBA3	7	0	40.5	47	X	-
APBA3	5	0	43.8	49	X	-
MYO3As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MYO3A	919	8	36.8	0	-	X
MYO3A	184	4	68.8	2	-	X
MYO3A	188	3	87.7	1	-	X
MYO3A	178	2	48.8	0	-	X
MYO3A	908	0	33.0	3	-	X
Myt1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDK1	15	7	76.7	0	X	X
CDK1	14	5	66.4	0	X	X
NDR1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
STK38	444	8	81.4	1	X	X
YAP1	61	7	69.4	0	-	X
STK38	281	5	76.8	1	X	X
KIF23	814	0	48.1	7	-	X
KIF23	716	0	28.2	6	-	X
YAP1	164	0	49.0	5	-	X
YAP1	127	0	41.9	31	X	X
YAP1	109	0	46.7	13	-	X
NDR2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NEK10s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NEK11s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDC25A	82	0	47.3	31	X	X
CDC25A	88	0	46.6	37	X	X
CDC25A	79	0	44.5	28	-	X
NEK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
VHL	202	9	95.6	0	-	X
VHL	175	9	98.0	0	-	X
VHL	112	8	97.4	0	-	X
VHL	105	7	98.6	1	-	X
VHL	183	6	97.6	0	-	X
VHL	168	6	98.1	0	-	X
VHL	100	4	98.7	1	-	X
NEK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CD274	194	12	98.0	0	X	X
CD274	210	12	97.8	0	X	X
CEP250	2417	11	73.6	0	-	X
CEP250	2064	9	44.4	0	X	-
CNTROB	41	9	84.8	0	X	-
CNTROB	35	9	75.6	0	X	-
CNTROB	36	9	78.2	0	X	-
CNTROB	45	9	84.9	0	X	-
NEK2	428	9	73.4	0	-	X
NEK2	170	9	46.6	0	-	X
NEK2	171	9	45.4	0	-	X
NEK2	356	9	83.0	0	-	X
DVL3	280	8	87.4	0	X	X
NPM1	88	8	98.3	0	X	-
SGO1	14	8	87.1	0	X	X
NEK2	241	6	97.6	1	-	X
NPM1	70	5	90.0	1	X	-
DVL3	15	1	89.5	3	X	X
NEK2	179	5	74.3	2	-	X
CEP250	2421	6	67.6	0	-	X
DVL3	697	6	42.3	0	X	X
NEK2	175	7	51.8	0	-	X
DVL3	643	0	35.7	49	X	X
NEK2	402	4	39.4	1	-	X
NEK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NEK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NEK6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KIF20A	754	9	61.3	0	-	X
KIF20A	683	9	51.8	0	-	X
KIF20A	240	9	38.9	0	-	X
KIF20A	244	8	36.7	0	-	X
RPS6KB1	412	8	82.9	1	-	X
SGK1	422	7	72.2	1	-	X
RPS6KB1	403	6	77.5	0	-	X
SGK1	377	1	88.5	2	-	X
KIF20A	883	0	35.6	7	-	X
RPS6KB1	53	0	32.7	14	-	X
STAT3	727	0	42.6	3	X	X
STAT3	705	0	57.4	5	-	X
NEK7s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KIF14	607	6	86.2	4	-	X
KIF14	1220	0	30.6	16	-	X
KIF14	1219	0	30.3	15	-	X
KIF14	56	0	29.6	295	-	X
KIF14	1217	0	30.8	13	-	X
NEK9s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NEK9	210	2	65.1	2	X	X
NEK9	944	0	31.4	7	X	X
Niks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
G6PD	40	9	97.4	0	X	X
ACTR2	238	6	95.0	1	X	X
ACTR2	237	6	94.9	1	X	X
ACTR2	202	5	94.4	1	X	X
CHUK	176	5	38.3	1	X	X
CHUK	180	4	45.9	1	X	-
G6PD	486	4	98.3	1	-	X
G6PD	8	4	63.3	1	-	X
IKBKB	177	3	67.2	1	X	-
IKBKB	181	3	71.2	2	X	-
G6PD	278	2	96.9	3	-	X
NFKBIA	36	2	67.6	0	-	X
NFKBIA	32	1	60.3	3	-	X
NFKB2	870	0	38.2	22	-	X
NFKB2	866	0	37.6	18	-	X
NLKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SMAD4	138	3	69.6	1	-	X
NCOA3	24	2	40.2	1	-	X
SMAD4	9	2	81.5	3	-	X
ESR1	104	0	34.8	80	X	-
ESR1	118	0	33.4	66	X	-
ESR1	106	0	35.0	78	X	-
ESR1	167	0	42.8	17	X	-
LEF1	166	0	42.4	104	X	X
LEF1	132	0	49.9	70	X	-
LEF1	200	0	48.6	105	X	-
LEF1	265	0	47.7	40	X	-
LEF1	155	0	45.5	93	X	X
NCOA3	857	0	36.1	48	-	X
NCOA3	860	0	36.1	51	-	X
NCOA3	543	0	32.9	14	-	X
TCF7L2	201	0	46.2	48	X	X
TCF7L2	212	0	41.7	59	X	X
NCOA3	505	0	39.2	22	-	X
NCOA3	867	0	31.5	58	-	X
NME1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NME1	120	11	98.3	1	-	X
NME1	118	7	98.5	0	X	X
NME1	44	5	98.3	1	-	X
NME2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NPM-ALKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
WAS	291	10	83.9	0	X	X
WAS	102	4	90.6	1	-	X
NuaK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TP53	15	4	53.9	1	X	-
PPP1R12A	472	0	51.5	35	X	X
PPP1R12A	910	0	32.5	22	X	X
PPP1R12A	445	0	37.1	8	X	X
TP53	392	0	48.5	35	X	-
NuaK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
OSR1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLC12A1	100	8	67.9	0	X	X
SLC12A1	105	6	62.1	0	X	-
SLC12A3	55	6	66.0	0	-	X
SLC12A2	212	5	64.0	0	X	X
SLC12A3	60	4	59.5	1	-	X
SLC12A2	217	3	58.3	0	-	X
SLC12A1	118	2	58.5	0	-	X
SLC12A1	120	2	50.3	1	-	X
SLC12A1	95	0	41.5	3	X	X
SLC12A2	207	0	31.1	4	X	X
SLC12A2	230	0	53.6	3	-	X
SLC12A2	203	0	25.6	8	X	X
SLC12A3	73	0	56.4	3	-	X
SLC12A3	46	0	25.6	8	-	X
P38As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RB1	567	10	97.1	1	X	X
KARS1	49	9	59.4	0	-	X
KARS1	52	9	51.0	0	X	X
DDX5	446	8	92.0	1	-	X
GSK3B	43	8	95.9	0	-	X
CDKN1A	57	7	93.0	0	-	X
ELAVL1	118	6	91.7	1	X	X
ELAVL1	88	6	90.7	0	X	-
F3	285	6	50.0	0	-	X
CDT1	491	5	87.3	1	X	X
ESR1	311	5	95.8	1	X	X
GSK3B	389	5	64.8	0	X	-
MAPKAPK2	334	5	93.8	1	X	X
ATF2	71	4	58.0	1	X	X
GSK3B	390	4	59.8	1	X	X
PTPN7	93	4	97.1	1	-	X
PTPN7	66	4	86.5	1	-	X
BCL2	87	1	77.1	4	X	X
MAFA	134	4	70.8	1	X	-
RB1	841	4	62.2	1	X	X
HSF1	326	4	52.5	1	X	X
MAPKAPK2	272	4	53.5	1	X	X
ATF2	69	0	54.1	3	X	X
BCL2	56	0	43.1	7	X	X
CDKN1A	98	0	42.1	21	-	X
CDKN1A	130	0	46.9	17	X	X
CDT1	391	0	38.8	5	X	X
CDT1	402	0	43.2	11	X	X
CDT1	411	1	52.9	2	X	X
TP53	15	4	53.9	1	X	X
RB1	252	2	47.5	1	X	X
RB1	249	2	52.5	1	X	X
MEF2A	108	3	51.1	1	X	-
RB1	838	1	49.6	2	X	X
P38Bs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SOD2	106	8	98.6	1	X	X
SOD2	79	6	98.4	0	X	X
MAPK11	261	5	90.2	0	-	X
ATF2	71	4	58.0	1	X	X
HSF1	326	4	52.5	1	-	X
MAPK11	241	4	93.0	2	-	X
E2F1	433	1	57.7	2	-	X
ATF2	69	0	54.1	3	X	X
E2F1	403	0	52.6	5	-	X
EGFR	1039	0	30.2	15	X	-
EGFR	1041	0	31.0	17	X	-
GYS1	727	0	38.0	40	-	X
GYS1	721	0	36.2	34	-	X
GYS1	653	0	30.8	12	-	X
GYS1	645	0	43.1	4	-	X
HSF1	303	0	44.1	24	-	X
SREBF1	426	0	42.9	22	-	X
SREBF1	63	0	38.2	18	-	X
HSF1	307	0	38.0	20	-	X
RPTOR	771	0	24.5	10	X	X
RPTOR	863	0	30.4	18	X	X
P38Ds, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GYS1	278	7	95.0	1	X	-
HSF1	326	4	52.5	1	-	X
EEF2K	359	3	74.5	1	X	X
SQSTM1	269	3	73.5	1	X	X
STMN1	25	1	77.0	2	X	X
EEF2K	396	0	32.0	35	-	X
GYS1	723	0	38.1	36	X	-
GYS1	727	0	38.0	40	X	-
HSF1	307	0	38.0	20	-	X
HSF1	303	0	44.1	24	-	X
SQSTM1	272	0	50.7	4	X	X
STMN1	38	0	64.6	8	X	X
P38Gs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GYS1	278	7	95.0	1	X	-
HSF1	326	4	52.5	1	X	X
SQSTM1	269	3	73.5	1	X	-
DLG1	443	0	35.9	23	X	-
DLG1	209	0	26.6	8	X	-
DLG1	158	0	29.2	11	X	-
GYS1	723	0	38.1	36	X	-
GYS1	727	0	38.0	40	X	-
HSF1	307	0	38.0	20	-	X
HSF1	303	0	44.1	24	-	X
MYOD1	201	0	49.8	22	-	X
MYOD1	200	0	52.8	21	-	X
NUP62	269	0	46.2	61	X	X
NUP62	272	0	45.2	58	X	X
SQSTM1	272	0	50.7	4	X	-
SREBF1	426	0	42.9	22	-	X
SREBF1	63	0	38.2	18	-	X
p70S6K iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
P70S6KBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HSPB1	78	9	52.2	0	X	-
HSPB1	82	8	60.4	0	X	-
HNRNPA1	4	0	45.1	7	X	X
HNRNPA1	6	0	54.4	5	X	X
p70S6Ks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RPS6	240	9	68.7	0	X	X
RPS6	244	9	59.6	0	X	X
RPS6	236	9	77.8	0	X	X
RPS6	235	9	80.0	0	X	X
NCBP1	22	7	61.5	0	X	-
NCBP1	21	6	57.8	0	X	-
PDCD4	67	2	46.6	2	X	-
PDCD4	457	2	48.4	1	X	-
BACH2	521	0	36.8	98	X	-
BACH2	520	0	37.8	99	X	-
DEPTOR	287	0	42.1	29	X	X
DEPTOR	286	0	41.9	30	X	X
DEPTOR	291	0	38.5	25	X	X
IRS1	636	0	53.0	23	X	X
IRS1	307	0	39.7	43	X	X
POLDIP3	385	0	45.1	10	X	X
IRS1	270	0	43.2	6	X	X
POLDIP3	383	0	42.5	12	X	X
IRS1	1101	0	40.8	441	X	X
MTOR	2446	0	33.1	9	X	X
MTOR	2448	0	32.8	11	X	X
NDRG2	332	0	38.0	12	-	X
NCBP1	7	0	40.1	13	X	-
IRS1	527	0	40.2	132	-	X
p90RSKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RPS6KA1	110	10	72.7	0	-	X
RPS6	236	9	77.8	0	X	X
RPS6	235	9	80.0	0	X	X
RPS6KA1	421	9	95.1	0	-	X
TBC1D4	570	9	43.0	0	-	X
TBC1D4	568	9	44.5	0	-	X
APAF1	268	6	85.2	0	X	X
APAF1	357	5	56.3	0	X	X
PDCD4	457	2	48.4	1	X	X
RPS6KA1	335	1	90.7	3	-	X
UBR5	1227	1	82.4	2	-	X
ARHGAP31	1106	0	31.9	77	X	-
ARHGAP31	1178	0	42.7	5	X	-
CDC25A	295	0	41.3	28	X	X
CDC25A	293	0	44.2	30	X	X
CDC25B	355	0	48.0	23	X	X
CDC25B	353	0	47.6	25	X	X
TBC1D4	341	0	27.4	5	-	X
UBR5	637	0	37.6	5	-	X
EIF4B	422	0	41.7	10	X	X
CIC	301	0	35.6	27	X	X
CIC	173	0	40.2	23	X	X
DEPTOR	287	0	42.1	29	X	X
DEPTOR	286	0	41.9	30	X	X
DEPTOR	291	0	38.5	25	X	X
PAK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ARHGDIA	176	13	94.7	0	X	-
ARHGDIA	101	11	92.9	0	X	X
ARHGDIA	174	10	93.9	0	X	X
AURKA	342	10	95.0	0	-	X
FLNA	2370	10	64.9	1	-	X
BAD	118	9	83.4	0	X	X
CTNNB1	675	9	80.7	0	X	X
FLNA	2292	9	74.2	0	-	X
GDI2	248	9	88.4	0	-	X
GIT1	700	9	91.9	0	-	X
PCBP1	60	9	89.2	2	X	X
PCBP1	127	9	89.8	0	X	X
GDI2	382	8	98.1	0	-	X
NLRP3	163	8	91.3	0	-	X
CTNNB1	552	7	75.3	0	X	-
TBCB	65	7	97.6	0	X	X
PGAM1	23	7	95.7	1	X	X
STMN1	16	5	92.5	0	X	X
TBCB	128	6	91.0	0	X	X
PGAM1	118	7	89.1	1	X	X
CTTN	113	2	59.7	0	X	-
MICAL1	817	6	51.2	0	-	X
MICAL1	960	5	72.0	0	-	X
PXN	272	7	72.3	0	X	X
NLRP3	659	6	75.1	1	X	X
KIF2C	192	4	74.4	1	X	X
ARHGEF2	886	0	37.3	4	X	X
ARHGEF2	885	0	None	100000	X	-
ILK	246	7	87.3	2	X	X
BAD	134	2	59.3	1	X	X
ILK	173	1	46.8	2	X	X
PAK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CASP7	239	14	93.8	0	X	X
SMAD2	417	10	98.2	0	X	X
JUN	286	9	98.5	0	X	X
CALD1	744	7	69.8	0	-	X
CALD1	714	7	59.2	0	-	X
PXN	272	7	72.3	0	X	-
ARHGAP15	292	6	96.3	1	-	X
MICAL1	817	6	51.2	0	-	X
PAK2	192	6	67.5	1	-	X
CASP7	173	5	94.7	0	X	X
MICAL1	960	5	72.0	0	-	X
PXN	274	5	68.0	0	X	-
PAK2	402	3	81.4	2	-	X
JUN	8	2	59.7	1	X	X
PAK2	141	2	42.8	2	-	X
SMAD2	465	0	85.2	10	-	X
SMAD2	464	0	85.1	9	-	X
SMAD2	467	0	84.8	12	-	X
ABL1	619	0	34.9	98	X	X
ABL1	618	0	34.9	97	X	X
ARHGAP15	4	0	43.3	76	-	X
ARHGAP15	43	0	42.6	37	-	X
ARHGAP15	41	0	41.0	39	-	X
CASP7	30	0	33.5	8	X	X
JUN	2	0	55.3	7	X	X
PAK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PAK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ITGB5	759	9	79.8	0	X	X
ITGB5	762	9	72.2	0	X	X
SNAI2	254	6	87.7	0	X	X
SNAI2	158	4	65.9	1	X	X
WASL	484	4	63.2	1	-	X
WASL	485	1	58.8	2	-	X
PAK5s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GATA1	161	0	42.6	25	X	X
GATA1	187	0	48.4	18	X	-
PAK6s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CTBP1	158	4	97.0	1	-	X
CTBP1	100	1	97.2	3	-	X
MDM2	186	0	42.9	9	X	X
MDM2	158	0	42.6	37	X	X
PASKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PASK	1161	8	78.7	0	-	X
PASK	307	6	62.0	1	X	-
PASK	1165	3	83.2	1	-	X
PBKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
JUN	73	5	63.4	0	X	X
JUN	63	0	49.4	10	X	X
ULK1	469	0	36.7	22	X	X
ULK1	533	0	37.0	86	X	X
ULK1	495	0	27.2	48	X	X
PCK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDGFRAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDGFRA	574	6	73.1	2	X	-
PDGFRA	572	5	68.3	0	X	-
PDGFRA	988	2	31.0	2	-	X
PDGFRA	1018	0	29.1	32	-	X
PDGFRBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ABL2	303	14	91.7	0	-	X
PTK2	194	11	89.0	0	X	X
ABL2	161	9	91.8	0	-	X
PDGFRB	857	9	68.4	1	X	X
ABL2	139	8	92.9	0	-	X
ABL2	116	6	89.9	2	-	X
ABL2	310	6	88.0	0	-	X
PDGFRB	581	6	61.2	2	-	X
PDGFRB	579	5	56.5	0	-	X
ABL2	299	4	73.5	2	-	X
ABL2	439	3	80.3	0	-	X
PDGFRB	562	3	66.2	4	-	X
PDGFRB	775	2	31.4	1	X	-
PDGFRB	778	2	31.7	1	X	-
ABL2	272	1	88.8	6	-	X
ETV6	17	0	49.8	23	X	X
ETV6	27	0	45.4	13	X	X
PDGFRB	771	0	30.4	5	X	X
MUC1	1218	0	36.7	28	-	X
MUC1	1203	0	33.9	13	-	X
PDGFRB	1021	0	28.2	30	X	X
PDHK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDHA2	230	9	98.0	0	-	X
PDHA2	291	2	98.2	1	-	X
PDHA2	298	1	97.6	4	-	X
PDHK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDHA1	232	9	98.4	0	-	X
PDHA1	293	2	98.1	1	-	X
PDHA2	291	2	98.2	1	-	X
PDHA1	300	1	97.7	4	-	X
PDHA2	298	1	97.6	4	-	X
PDHK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDHA1	293	2	98.1	1	-	X
PDHA2	291	2	98.2	1	-	X
PDHA1	300	1	97.7	4	-	X
PDHA2	298	1	97.6	4	-	X
PDHK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDHA1	232	9	98.4	0	X	-
PDHA1	293	2	98.1	1	X	X
PDHA2	291	2	98.2	1	-	X
PDHA1	300	1	97.7	4	-	X
PDHA2	298	1	97.6	4	-	X
PDK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDPK1	513	8	85.9	0	-	X
RPS6KB1	412	8	82.9	1	X	X
AKT1	473	7	82.0	1	X	X
PDPK1	410	4	71.6	1	X	X
RPS6KB1	252	3	84.5	2	X	X
AKT1	308	2	72.1	2	X	X
PKN1	773	2	82.0	1	-	X
PKN1	774	2	71.8	2	X	X
PDPK1	393	0	31.9	9	X	X
PDPK1	25	0	33.9	54	X	X
PDPK1	396	0	31.9	12	X	X
PDPK1	241	0	65.9	3	X	X
RPS6KB1	229	0	None	100000	-	X
RPS6KB1	394	0	84.1	6	X	-
PERKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EIF2S1	49	5	79.2	0	-	X
EIF2S1	52	5	77.3	1	X	X
PFKFB3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PFKPs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PGK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PHKA1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PHKG1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PIK3C2As, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PIK3CAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RPS6KB1	412	8	82.9	1	X	-
RPS6KB1	252	3	84.5	2	X	-
PIK3CBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PIK3CDs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PIK3CGs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SRC	39	0	40.0	49	-	X
SRC	70	0	29.1	18	-	X
PIK3R1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Pim1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LDHA	161	14	98.3	1	X	X
LDHA	319	12	96.3	0	-	X
RUNX3	153	11	98.3	0	X	-
RUNX3	155	10	98.2	0	X	-
CAPZA1	126	9	97.7	0	X	X
HBP1	372	9	77.8	0	X	X
NKX3-1	186	9	79.6	0	-	X
NKX3-1	185	9	84.1	0	-	X
POU5F1	288	9	68.0	0	-	X
POU5F1	289	9	64.0	0	-	X
RUNX3	151	9	98.2	2	X	-
CAPZA1	106	8	97.4	0	X	X
HBP1	380	8	66.3	0	X	X
AR	851	6	86.5	0	X	X
NKX3-1	195	5	52.7	0	-	X
RUNX3	149	5	97.9	4	X	-
SKP2	417	5	86.2	0	X	-
CDKN1A	145	1	72.9	2	X	X
CDKN1A	146	3	71.7	1	-	X
NKX3-1	196	4	50.3	1	-	X
AR	215	0	35.8	19	X	X
AR	220	0	33.3	14	X	-
NFATC1	154	2	51.2	3	X	-
CDKN1B	157	0	56.2	60	X	X
CDKN1B	198	0	69.3	101	X	X
FOXO3	32	3	57.9	1	X	-
Pim2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LDHA	161	14	98.3	1	X	X
LDHA	319	12	96.3	0	-	X
CDKN1A	146	3	71.7	1	-	X
CDKN1A	145	1	72.9	2	X	X
Pim3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LDHA	161	14	98.3	1	X	X
LDHA	319	12	96.3	0	-	X
PINK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MFN2	442	11	84.9	0	X	-
PINK1	257	11	65.8	0	X	X
MFN2	111	10	92.8	0	X	-
MFN2	378	9	93.4	0	X	-
PINK1	228	5	92.4	2	X	X
PINK1	402	2	93.8	1	X	X
ZNF746	613	2	48.9	2	X	-
ZNF746	322	0	24.7	16	X	-
PKACA iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PKACAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TRPA1	317	16	89.6	0	X	-
KCNN2	135	15	93.0	0	-	X
DAP3	185	14	93.1	0	-	X
CTNNB1	179	13	96.1	0	-	X
CAPN2	369	12	88.8	0	X	-
CASP9	183	12	94.9	0	X	X
CCND1	234	12	93.1	0	-	X
CFTR	660	12	62.2	0	X	X
PTPN12	39	12	95.5	0	X	X
SNAP25	29	12	95.9	0	-	X
SNAP25	187	12	91.1	0	-	X
TFAM	61	12	97.7	0	-	X
TRPA1	428	12	81.1	0	X	-
CASP9	195	11	97.6	0	-	X
NCF1	328	11	91.0	0	-	X
NDE1	131	9	98.6	0	X	X
PIN1	71	0	98.4	5	-	X
ALOX5	272	6	98.3	1	-	X
ALOX5	448	6	98.3	0	-	X
STMN1	63	9	98.3	0	-	X
TGM2	216	9	98.3	1	-	X
TGM2	215	6	98.2	0	-	X
CSNK1A1	218	4	98.1	2	X	-
CSNK1A1	242	5	98.0	0	X	-
TFAM	56	10	97.8	0	-	X
TFAM	55	7	97.8	1	X	X
ALOX5	524	6	97.7	0	X	X
ALOX5	671	9	97.6	2	-	X
ABCA1	1042	10	83.4	0	-	X
ABCA1	2054	10	83.7	0	-	X
ABCB1	683	9	45.3	0	-	X
ADRB2	346	2	48.6	0	-	X
ADRB2	261	9	62.7	0	X	-
ADRB2	262	10	66.7	0	X	-
AICDA	38	6	85.8	0	X	X
BAD	118	9	83.4	0	X	-
CAD	1406	3	51.9	0	X	X
CAPN1	418	9	88.2	0	-	X
CAPN2	370	9	90.7	0	X	X
CDK16	153	10	58.2	0	X	X
DUOX1	1217	10	84.2	1	X	X
CAPN1	474	8	94.0	1	-	X
PFN1	72	11	97.4	0	X	-
CIITA	1050	8	94.0	0	X	X
GFPT1	205	8	90.4	1	-	X
CIITA	834	7	92.1	0	-	X
STAR	195	7	95.0	0	X	-
AICDA	27	6	92.6	1	X	X
HSPB1	143	5	93.3	1	-	X
PIN1	16	7	94.8	1	X	X
GLI1	374	7	81.5	1	-	X
IGFBP1	199	3	80.8	1	X	-
GPKOW	316	5	39.7	1	X	X
CCND1	90	9	94.9	0	-	X
ESR1	236	5	95.6	0	X	X
ETV1	334	4	73.2	0	X	X
TNFRSF1A	417	8	69.7	1	X	-
TPH1	260	4	89.3	0	-	X
CCND1	197	5	92.2	0	-	X
PKACBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SRSF2	121	0	45.5	19	X	-
SRSF2	171	0	51.5	69	X	-
SRSF2	128	0	43.3	26	X	-
SRSF2	130	0	43.6	28	X	-
PKCAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KCNJ1	201	13	94.5	0	-	X
SLC6A2	258	13	94.1	0	X	-
SLC6A2	259	13	95.4	0	X	-
SLC6A4	277	13	95.5	0	-	X
CFTR	660	12	62.2	0	-	X
CTPS1	455	12	96.7	0	X	X
CYP3A4	92	12	97.8	0	-	X
DTNB	179	12	95.8	0	-	X
PTPN12	39	12	95.5	0	X	X
RIGI	170	12	90.0	0	X	X
SLC6A4	149	12	93.4	0	-	X
SNAP25	187	12	91.1	0	X	X
ADAP1	276	11	97.4	0	-	X
CSNK1D	53	11	94.7	0	X	X
CYP3A4	420	11	96.6	1	-	X
CSNK1D	191	7	98.6	1	-	X
RRAD	214	5	98.5	1	-	X
ADAP1	87	9	98.3	0	-	X
MMP2	160	8	98.3	0	-	X
CYP3A4	100	5	98.2	0	-	X
SRF	162	9	98.2	0	X	X
CSNK1D	161	4	98.1	0	-	X
CYP3A4	103	9	98.1	2	-	X
SRF	159	9	98.1	0	X	X
CYP3A4	398	9	98.0	0	-	X
CSNK1D	181	9	97.9	1	X	X
SHOC2	297	0	97.9	4	-	X
ANXA2	26	9	97.2	2	X	X
ACO1	711	9	91.8	0	X	-
ACO1	138	8	96.1	0	-	X
ADRA1D	334	9	68.6	0	X	-
ADRA1D	332	9	62.9	0	X	-
ADRA1D	516	9	44.9	0	X	-
ADRA1D	518	9	45.4	0	X	-
AHR	36	6	91.7	0	-	X
ANXA1	27	6	93.4	0	-	X
ANXA2	12	6	41.3	0	X	-
AQP1	157	7	95.8	0	X	X
AQP1	239	6	89.9	0	X	X
ARHGDIA	96	6	92.7	0	X	X
C5AR1	332	7	36.2	0	-	X
CFTR	641	10	69.6	0	X	-
HRH1	478	10	93.9	0	-	X
TBXA2R	145	10	75.6	0	X	-
CASR	875	10	63.2	0	X	-
ELAVL1	318	9	93.9	0	X	-
AKT1	473	7	82.0	1	X	X
KCNJ1	193	8	91.8	0	X	-
TUBA1C	165	8	93.0	0	X	-
MMP2	377	6	91.8	1	-	X
PPP1R14A	38	5	63.0	0	-	X
MMP2	378	6	94.1	2	-	X
PLD2	243	9	93.6	1	X	-
PRKD1	412	3	53.6	3	-	X
CTPS1	462	6	96.0	1	X	X
PRKCE	316	9	41.5	0	-	X
PRKCE	234	5	38.4	1	-	X
C5AR1	334	8	37.6	0	-	X
CDKN1A	153	4	62.0	0	X	X
DTNB	69	5	96.0	0	-	X
PLD2	252	4	85.5	0	X	-
TRPV5	654	9	56.9	0	X	-
CDKN1A	146	3	71.7	1	-	X
CELF1	173	3	78.7	2	X	-
PKCB iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MFN1	284	12	93.5	1	-	X
NCF1	328	11	91.0	0	-	X
MFN1	290	9	88.3	0	-	X
SYT6	417	9	98.3	1	-	X
SYT6	283	8	96.4	1	-	X
MFN1	86	7	92.7	1	X	X
PPARA	230	6	90.5	0	-	X
PPARA	179	6	78.8	0	-	X
NCF1	379	5	70.2	1	-	X
ITGB2	745	4	62.9	1	-	X
NCF1	320	4	92.2	1	-	X
NCF1	370	4	73.7	1	-	X
SYT6	418	4	98.2	2	-	X
TRPV6	184	3	95.1	0	X	-
NCF1	303	2	94.5	0	-	X
NCF1	304	2	94.8	0	-	X
NCF1	315	0	83.9	6	-	X
ITGB2	758	0	60.1	5	-	X
LMNB1	405	0	39.4	16	X	X
LMNB1	395	0	47.0	6	X	X
TRPV6	728	2	37.4	2	X	-
PKCBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NCF1	328	11	91.0	0	-	X
AKT1	473	7	82.0	1	-	X
IBTK	1203	5	59.0	1	X	X
ITGB2	745	4	62.9	1	-	X
KCNC4	21	4	43.8	1	-	X
NCF1	320	4	92.2	1	-	X
SHC1	206	4	65.9	0	-	X
SHC1	213	4	64.3	1	-	X
AKT1	308	2	72.1	2	-	X
NCF1	304	2	94.8	0	-	X
SHC1	139	1	59.9	5	X	X
STMN1	25	1	77.0	2	X	-
IBTK	1200	0	53.0	4	X	X
IRS1	323	0	37.7	59	-	X
IRS1	441	0	36.4	177	-	X
NCF1	315	0	83.9	6	-	X
MSX2	141	0	73.5	10	X	X
MARCKS	159	0	72.5	8	X	-
MARCKS	163	0	71.3	4	X	-
MSX2	135	0	64.7	16	X	X
STMN1	38	0	64.6	8	X	-
TRPM8	1041	0	30.9	4	X	-
ITGB2	758	0	60.1	5	-	X
KCNC4	9	0	35.4	13	-	X
KCNC4	8	0	36.9	14	-	X
KCNC4	15	0	36.2	7	-	X
PKCDs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DAP3	237	15	93.0	0	-	X
DAP3	185	14	93.1	0	-	X
GAPDH	246	12	98.8	0	X	X
BLVRA	230	11	96.0	0	X	X
NCF1	328	11	91.0	0	-	X
BLVRA	33	10	96.1	0	X	X
GAPDH	241	10	98.8	0	-	X
TRPV4	162	10	85.2	1	X	-
BLVRA	237	9	95.9	0	X	X
CXCR4	324	9	58.9	0	X	-
CXCR4	325	9	56.5	0	X	-
DAP3	186	9	92.3	0	-	X
ELAVL1	318	9	93.9	0	X	X
PRKCD	295	9	60.4	0	-	X
RPS6	235	9	80.0	0	X	-
SHOC2	297	0	97.9	4	-	X
BLVRA	21	8	97.6	0	X	X
NCF1	304	2	94.8	0	X	X
NCF1	303	2	94.5	0	-	X
TNNI3	44	6	93.8	0	-	X
RPS3	6	4	93.0	1	X	X
PRKCD	503	3	92.4	1	-	X
RPS6	236	9	77.8	0	X	-
TRPV4	175	7	83.0	0	X	-
NCF1	379	5	70.2	1	X	X
PRKCD	299	7	50.1	0	X	X
PRKD1	412	3	53.6	3	X	X
PRKCD	645	1	84.1	4	-	X
DAP3	31	0	33.7	19	-	X
DAP3	280	3	90.9	2	-	X
PRKCD	218	4	40.3	0	-	X
TRPV4	189	3	67.9	0	X	-
ITGB2	745	4	62.9	1	-	X
PRKCD	302	4	41.5	1	-	X
PRKD1	738	3	61.9	1	X	X
TNNI3	24	2	51.4	2	-	X
PKCEs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ALDH2	202	13	98.9	0	-	X
ADAP1	276	11	97.4	0	-	X
ADAP1	87	9	98.3	0	-	X
BAD	118	9	83.4	0	X	-
GNAI2	302	9	98.3	0	X	-
PRKCE	316	9	41.5	0	-	X
ALDH2	296	8	98.8	0	-	X
GNAI2	144	8	97.2	0	X	-
KEAP1	602	8	97.4	0	X	X
PRKCE	729	8	92.4	1	X	X
GNAI2	44	7	97.6	1	X	-
NANOG	135	7	97.9	1	-	X
PRKCE	534	7	94.9	1	X	-
ALDH2	429	6	98.7	1	-	X
PRKD2	876	6	67.9	0	X	-
KEAP1	599	2	96.3	3	X	-
ITGB1	789	0	70.7	4	X	-
PRKCE	234	5	38.4	1	-	X
PRKCE	368	4	38.7	1	-	X
PRKD1	742	3	56.0	2	-	X
PRKD2	710	3	62.8	2	X	-
BAD	99	0	64.6	3	-	X
BAD	75	0	56.7	17	X	X
PRKD1	738	3	61.9	1	-	X
PRKD2	706	3	69.7	1	X	-
PKCGs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DNAJC5	34	11	93.1	0	X	X
HSP90AA1	425	10	97.1	0	X	X
HSP90AA1	115	7	84.0	0	X	X
DNAJC5	10	6	58.7	1	X	X
ARHGEF7	518	4	76.3	2	X	X
KCNC4	21	4	43.8	1	-	X
HSP90AA1	603	1	90.7	4	X	X
NADK	64	1	76.5	9	X	X
ARHGEF7	761	0	36.1	33	X	X
CD5	434	0	42.0	18	-	X
CD5	436	0	41.5	16	-	X
KCNC4	9	0	35.4	13	-	X
KCNC4	8	0	36.9	14	-	X
KCNC4	15	0	36.2	7	-	X
NADK	46	0	30.4	8	X	X
PKCHs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GSTP1	185	9	98.7	0	-	X
GSTP1	43	7	97.6	0	-	X
PRKCH	28	7	78.4	0	-	X
PRKD2	876	6	67.9	0	X	-
ITGB2	745	4	62.9	1	-	X
PRKCH	32	4	59.0	1	-	X
PRKD1	738	3	61.9	1	X	X
PRKD1	742	3	56.0	2	X	X
PRKD2	706	3	69.7	1	X	-
PRKD2	710	3	62.8	2	X	-
ITGB2	758	0	60.1	5	-	X
PTPN11	591	0	40.5	47	X	-
PTPN11	576	0	33.6	32	X	-
PKCIs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KLF10	445	10	80.8	0	-	X
AMOT	750	9	96.1	0	-	X
AMOT	536	9	88.5	0	-	X
AMOT	538	9	90.7	0	-	X
BAD	118	9	83.4	0	X	X
KLF10	384	6	86.1	0	-	X
ROCK1	1024	5	59.3	0	X	X
EZH2	690	4	93.1	1	-	X
GLI1	243	4	85.1	2	X	-
FBXW7	10	3	29.8	1	X	-
EZH2	345	2	45.4	2	-	X
GLI1	304	2	89.4	2	X	-
NUMB	295	2	64.0	1	-	X
NUMB	7	2	57.3	0	X	X
EZH2	487	1	58.6	10	-	X
BAD	99	0	64.6	3	X	X
NUMB	276	0	57.9	5	-	X
BAD	75	0	56.7	17	X	X
FBXW7	18	0	30.8	7	X	-
PKCTs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
LLGL1	663	9	46.5	0	X	-
LLGL1	659	9	45.3	0	X	-
PTPN7	246	9	95.1	0	-	X
CARD11	893	8	34.5	0	X	X
LLGL1	655	8	44.2	0	X	-
STK39	309	8	97.7	0	-	X
RANGAP1	504	7	94.1	1	X	-
LLGL1	670	6	42.4	0	X	-
ARHGEF6	488	4	87.8	2	X	X
STK39	323	4	94.5	0	-	X
HABP4	354	3	81.6	0	-	X
LLGL1	673	3	36.6	2	X	-
RANGAP1	506	3	93.5	0	X	-
ARHGEF6	225	0	33.6	9	X	X
BAD	75	0	56.7	17	-	X
PDPK1	241	0	65.9	3	X	-
BAD	99	0	64.6	3	-	X
FOSL1	265	0	59.1	94	X	-
FOSL1	230	0	57.2	59	X	-
FOSL1	223	0	55.8	52	X	-
PTPN7	44	0	51.7	5	-	X
PDPK1	64	0	48.4	15	X	-
CARD11	559	0	35.2	11	-	X
HABP4	375	0	47.7	19	-	X
PKCZs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AQP9	222	14	98.8	0	X	-
BLVRA	149	13	98.0	0	X	X
BLVRA	230	11	96.0	0	X	X
NCF1	328	11	91.0	0	-	X
KLF10	445	10	80.8	0	-	X
HMGB1	181	9	40.9	0	X	-
NCOA3	1059	9	78.1	0	X	-
OCLN	438	9	94.3	0	X	X
SP1	668	9	82.0	1	X	X
SP1	702	9	87.6	0	-	X
GSK3B	147	8	96.1	0	X	-
NCOA3	1064	8	77.9	1	X	-
NCOA3	1048	7	60.3	0	X	-
SP1	670	7	83.2	0	X	X
HMGB1	39	6	84.5	0	X	-
PHGDH	57	3	95.9	2	X	X
NCF1	304	2	94.8	0	X	X
PHGDH	55	2	94.3	2	X	X
PHGDH	78	5	92.5	3	X	X
NCF1	320	4	92.2	1	-	X
OCLN	424	4	91.9	2	X	X
HMGB1	53	5	91.0	1	X	-
KLF10	384	6	86.1	0	-	X
HABP4	354	3	81.6	0	-	X
NCOA3	1062	6	77.7	0	X	-
NCOA3	1067	6	77.8	0	X	-
ADARB1	211	0	40.7	21	X	X
ADARB1	216	0	36.4	16	X	X
AQP9	11	4	78.3	1	X	X
GSK3B	9	0	69.4	18	X	-
HABP4	375	0	47.7	19	-	X
IKBKB	177	3	67.2	1	-	X
IKBKB	181	3	71.2	2	-	X
SP1	681	6	81.0	0	X	X
PKDCCs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PKG1 iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HSPB1	78	9	52.2	0	-	X
HSPB1	82	8	60.4	0	-	X
HSPB1	143	5	93.3	1	-	X
HSPB1	15	0	40.7	3	-	X
PKG1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TRPC6	322	15	94.8	0	-	X
CBS	227	10	98.5	0	X	X
HRH1	398	9	78.7	0	-	X
HRH1	396	9	80.3	0	-	X
RGS2	46	9	76.3	0	X	X
TRPC1	206	9	85.1	0	X	-
VASP	278	8	72.7	0	X	X
CBS	525	7	79.4	0	X	X
TRPC1	347	5	90.0	0	X	-
GTF2I	784	4	92.6	0	X	X
GTF2I	412	4	91.9	0	X	X
CCDC80	434	0	33.8	142	-	X
CCDC80	409	0	38.4	117	-	X
GTF2I	743	0	None	100000	X	-
GTF2I	371	0	None	100000	X	-
VASP	239	0	54.2	7	X	X
VASP	157	0	41.4	13	X	X
RGS2	64	0	40.4	10	X	X
TRPC6	70	0	30.6	15	X	X
PKG2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NOS3	1177	10	67.4	0	-	X
PDGFRB	254	6	84.3	0	X	-
NOS3	633	5	39.9	2	-	X
EGFR	430	4	86.3	2	X	X
NOS3	495	4	45.6	1	-	X
EGFR	693	0	37.5	8	X	-
PDGFRB	712	0	32.8	4	X	-
PTPN6	557	0	35.3	19	X	-
PTPN6	556	0	33.6	18	X	-
PTPN6	553	0	33.6	15	X	-
PKM iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PKMs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AKT1S1	203	0	47.7	12	X	X
AKT1S1	202	0	46.2	13	X	X
MDM2	351	0	37.8	23	-	X
MDM2	166	0	44.1	29	-	X
PKN1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MEFV	208	0	34.3	51	X	X
MEFV	242	0	40.9	17	X	X
PKN2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MEFV	208	0	34.3	51	-	X
MEFV	242	0	40.9	17	-	X
PKN3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PKRs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EIF2AK2	162	12	86.4	0	X	X
EIF2AK2	293	11	96.2	0	X	X
EIF2AK2	101	10	83.9	0	X	X
EIF2AK2	258	7	87.3	0	X	X
EIF2AK2	83	6	54.7	0	-	X
EIF2AK2	6	4	68.5	1	X	-
EIF2AK2	255	4	78.5	1	X	X
EIF2AK2	451	3	83.7	1	X	X
EIF2AK2	446	1	72.1	2	X	X
EIF2AK2	242	0	48.4	14	X	X
EIF2AK2	89	0	30.3	5	-	X
EIF2AK2	88	0	31.4	4	-	X
EIF2AK2	90	0	29.6	6	-	X
PLK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ATXN10	82	14	96.5	0	X	X
ATXN10	77	13	93.5	0	X	X
PCNT	1235	13	65.0	0	-	X
KIF2C	715	11	76.3	0	X	-
BUB1B	1008	10	90.1	0	X	X
KIF2C	633	10	78.8	0	-	X
PCNT	1241	10	61.5	0	-	X
BRF1	270	9	88.8	1	X	-
C1orf112	744	9	80.8	0	-	X
CDC25B	127	9	86.0	0	-	X
CENPQ	138	9	79.9	0	X	X
CENPQ	256	9	91.8	0	X	X
CENPQ	253	9	91.2	0	X	X
CENPQ	139	9	81.0	0	X	X
CENPQ	255	9	91.1	0	X	X
PPP1R7	277	6	98.5	1	-	X
BIRC5	20	7	97.3	0	X	X
BIRC5	21	8	97.2	0	-	X
CDC25B	513	4	96.7	1	-	X
CDC25B	465	8	96.5	0	-	X
CHEK2	164	4	96.2	2	X	-
STK38	183	6	95.8	2	X	X
TNKS	839	7	95.8	1	X	X
USP16	386	8	95.4	0	X	X
CDC25B	404	3	95.3	1	-	X
CDC25B	397	3	95.2	2	-	X
PTPN1	286	7	93.5	0	-	X
TTK	594	4	92.7	1	-	X
BRF1	450	3	66.7	0	X	-
BUB1B	792	7	77.0	0	X	X
C1orf112	43	6	84.4	0	X	X
CCNB1	147	8	55.4	0	X	X
CDC25B	291	7	69.9	0	-	X
CDC25B	58	8	60.3	0	-	X
CDC27	446	5	54.6	0	-	X
KIF2C	632	9	76.2	0	-	X
NINL	686	9	90.7	0	-	X
TTK	108	9	92.1	0	-	X
VIM	459	9	75.4	0	X	X
RACGAP1	214	5	54.2	0	-	X
CHEK2	205	6	81.3	0	X	-
MAD1L1	680	7	82.8	1	X	-
CENPQ	123	6	81.9	0	X	X
STK38	407	5	92.1	1	X	X
ANAPC1	520	0	34.1	7	-	X
ANAPC1	377	0	32.9	30	-	X
FOXM1	730	6	57.0	0	X	X
RBBP8	723	5	59.9	0	X	X
TTK	33	7	40.1	0	-	X
RBBP8	731	4	58.6	1	-	X
STIL	1108	4	39.4	0	X	X
NUDC	274	3	62.1	2	X	X
TTK	46	3	56.3	0	-	X
BRCA2	193	2	46.2	2	X	X
PLK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CALU	196	9	79.6	0	-	X
CALU	60	8	65.3	0	-	X
CALU	44	7	57.2	0	-	X
FBXW7	349	7	93.8	1	-	X
CENPJ	595	6	62.8	0	X	X
FBXW7	25	5	37.0	0	-	X
CENPJ	589	3	60.7	2	X	X
FBXW7	176	0	32.9	35	X	X
PLK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CALU	254	12	86.7	0	-	X
CALU	177	12	90.2	0	-	X
CALU	196	9	79.6	0	-	X
CALU	60	8	65.3	0	-	X
CALU	44	7	57.2	0	-	X
JUN	73	5	63.4	0	X	-
ATF2	71	4	58.0	1	-	X
ATF2	69	0	54.1	3	-	X
CDC25C	191	0	38.1	78	-	X
CDC25C	198	0	35.1	71	-	X
CHEK2	62	0	39.5	32	-	X
CHEK2	73	0	40.6	21	-	X
HIF1A	657	0	35.9	51	X	X
HIF1A	576	0	35.1	36	X	X
JUN	63	0	49.4	10	X	-
PTEN	370	0	39.1	17	-	X
PTEN	366	0	38.0	17	-	X
PLK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
NEDD1	568	14	81.0	0	X	X
NEDD1	23	8	92.0	0	X	X
PLK4	177	7	92.2	0	-	X
ACTR2	238	6	95.0	1	X	X
ACTR2	237	6	94.9	1	X	X
NEDD1	303	5	59.8	0	X	X
STIL	1116	4	68.5	1	X	X
PLK4	170	3	67.5	2	-	X
PLK4	22	2	87.1	2	-	X
CEP131	78	0	32.5	180	X	X
CEP131	205	0	36.0	53	-	X
CEP131	21	0	35.8	237	X	X
NEDD1	338	0	32.5	28	X	X
NEDD1	404	0	30.8	94	X	X
NEDD1	325	0	28.7	15	X	X
STIL	428	0	41.9	55	X	X
PLK4	305	0	32.4	39	X	X
PRKD1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
AP2B1	258	14	95.3	0	X	-
SSH1	402	11	96.5	0	-	X
AP2B1	277	10	92.6	0	X	-
BAD	118	9	83.4	0	X	X
CTTN	348	9	68.0	0	X	X
PTRH2	87	9	97.6	0	X	X
SSH1	978	8	49.4	0	X	X
AKT1	473	7	82.0	1	X	-
PTRH2	5	7	60.2	0	X	-
CREB1	119	6	94.9	0	X	X
TFAP2A	326	6	86.0	2	-	X
PAK4	99	5	62.7	0	X	X
PRKD1	910	5	56.2	0	X	X
CTNNB1	120	4	80.2	1	X	X
RIN1	351	4	45.0	1	X	X
PAK4	474	3	94.1	2	-	X
TFAP2A	258	3	87.3	1	-	X
CTNNB1	112	0	74.6	4	X	X
AKT1	308	2	72.1	2	X	-
BAD	99	0	64.6	3	-	X
CTTN	298	3	64.5	0	X	X
PRKD1	738	3	61.9	1	X	-
KAT7	331	3	50.8	3	X	X
ATP7B	1453	0	29.8	9	-	X
ATP7B	1121	0	32.9	5	-	X
ATP7B	481	0	30.9	9	-	X
ATP7B	478	0	28.2	12	-	X
BAD	75	0	56.7	17	X	X
CREB1	98	0	None	100000	-	X
PRKD1	742	3	56.0	2	X	-
PRKD2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SSH1	978	8	49.4	0	X	-
SSH1	937	0	31.4	11	X	-
VASP	239	0	54.2	7	X	-
VASP	157	0	41.4	13	X	-
VASP	322	0	45.3	12	X	-
PRKD3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PRKD1	738	3	61.9	1	X	-
PRKD1	742	3	56.0	2	X	-
PRKXs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PRP4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PRPKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Pyk2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ID3	48	11	87.5	0	X	X
NPHP1	46	11	87.9	0	X	-
ID3	18	9	73.8	0	X	-
ID3	11	9	67.9	0	X	X
NPHP1	349	8	86.0	0	X	-
ID3	5	4	60.2	1	X	X
CTTN	470	0	40.9	22	X	X
CTTN	486	0	44.3	6	X	X
CTTN	421	0	42.7	22	X	X
QIKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CEP250	2394	12	79.1	0	X	X
CEP250	2392	9	79.5	0	X	X
PIK3R1	541	9	97.1	0	X	X
SIK2	90	5	93.5	1	-	X
SIK2	343	5	66.1	0	-	X
PIK3R1	154	3	87.7	3	-	X
SIK2	358	3	66.0	2	-	X
LRP6	1490	0	37.9	98	X	X
LRP6	1420	0	33.5	28	X	X
QSKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RAF1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BAD	118	9	83.4	0	X	X
MAP2K1	222	9	67.2	0	X	X
MAP2K1	218	8	77.3	0	X	X
RAF1	338	5	70.1	0	X	-
RAF1	359	2	72.2	2	X	-
BAD	75	0	56.7	17	X	X
BAD	99	0	64.6	3	X	-
RAF1	621	0	43.2	9	X	X
RAF1	259	0	70.5	9	X	-
Ret iso3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Rets, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RET	809	10	93.1	0	-	X
ATF4	115	9	61.0	0	X	X
ATF4	114	9	62.0	0	X	X
ATF4	119	8	56.7	0	X	X
PTK2	925	8	87.3	0	-	X
RET	981	8	94.3	0	X	X
RET	806	7	94.3	1	-	X
PTK2	577	5	61.6	0	X	X
RET	1015	5	49.4	0	-	X
ATF4	107	4	58.6	0	X	X
PTK2	576	4	64.2	1	X	X
RET	900	4	56.7	0	-	X
MAPK3	202	3	68.3	1	X	-
RET	826	2	46.2	0	-	X
RET	1029	2	35.9	2	-	X
MAPK3	204	1	73.5	3	X	X
PTK2	861	0	34.2	28	-	X
RET	1090	0	29.2	63	-	X
RET	1096	0	28.1	69	-	X
RIOK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RIOK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RIPK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RIPK1	166	12	78.4	0	X	X
RIPK1	20	10	85.0	0	-	X
RIPK1	161	7	82.7	0	-	X
RIPK1	14	6	88.2	0	-	X
RIPK1	15	5	84.7	0	-	X
RIPK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RIPK2	174	12	58.2	0	-	X
RIPK2	474	10	92.1	0	X	X
RIPK2	176	8	46.3	0	X	X
RIPK2	178	7	44.4	0	-	X
RIPK2	180	4	41.1	0	-	X
RIPK2	181	3	39.6	1	-	X
RIPK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MLKL	358	10	77.8	0	X	X
MLKL	357	8	75.5	0	X	X
RIPK3	227	6	80.3	0	X	X
RIPK3	182	3	85.4	1	-	X
RIPK3	224	2	80.5	2	X	-
ROCK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DAPK3	299	9	87.1	1	-	X
FHOD1	1137	9	82.9	1	X	X
SCRIB	1508	9	67.9	0	X	X
MYL12B	19	8	68.8	0	X	X
MYL9	19	8	68.4	0	X	-
ADD1	445	7	50.5	0	X	X
FHOD1	1141	7	70.4	0	X	X
ARHGAP35	1173	6	46.6	0	-	X
DAPK3	265	6	97.5	1	X	X
MYL12B	20	6	65.6	0	X	X
MYL9	20	6	65.5	0	X	X
PTEN	232	6	96.7	1	X	X
ARHGAP35	1174	5	43.0	0	-	X
FHOD1	1131	4	77.5	2	X	X
NR3C1	617	4	84.6	1	-	X
PTEN	229	3	95.4	3	X	X
KCNK3	393	0	57.6	70	X	-
ADD1	480	0	36.5	8	X	X
ARHGAP24	391	0	37.0	63	X	-
ARHGAP24	452	0	33.7	124	X	-
ARHGAP24	437	0	34.0	109	X	-
ARHGAP24	415	0	41.5	87	X	-
ARHGAP24	413	0	40.5	85	X	-
ARHGAP24	402	0	35.2	74	X	-
ARHGAP35	1236	0	30.2	15	-	X
ARHGAP35	1150	0	30.6	10	X	X
ARHGAP35	1226	0	32.5	25	-	X
ROCK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PPP1R12A	696	2	54.8	2	X	-
PPP1R12A	695	0	None	100000	-	X
ROCK2	1374	0	32.5	16	-	X
ROCK2	1366	0	35.0	8	-	X
ROCK2	1379	0	33.5	21	-	X
Rons, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ABL1	393	2	83.5	5	X	-
MET	1356	2	62.0	13	X	-
ABL1	226	1	92.2	6	X	-
MET	1349	0	58.4	6	X	-
MET	1234	0	53.5	3	X	-
MET	1235	0	56.4	3	X	-
ROR1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RSK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP3K5	1109	12	87.6	0	X	X
RPS6	236	9	77.8	0	-	X
RPS6	235	9	80.0	0	-	X
MAP3K5	1326	7	87.1	0	X	X
NFATC4	676	6	91.8	1	X	X
PPP1R3A	65	2	78.0	2	-	X
BAD	99	0	64.6	3	-	X
BAD	75	0	56.7	17	X	X
FOXN2	369	0	45.4	14	X	-
FOXN2	365	0	50.9	18	X	-
MAP3K5	83	0	27.6	10	X	X
NFATC4	289	0	39.8	81	X	X
NFATC4	281	0	35.8	73	X	X
NFATC4	344	0	40.3	39	X	X
NFATC4	285	0	37.5	77	X	X
TBX21	503	0	49.0	169	X	X
PPP1R3A	46	0	45.3	21	-	X
TBX21	507	0	44.0	173	X	X
WWC1	947	0	41.8	13	X	X
WWC1	929	0	36.0	31	X	X
RSK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RPS6KA2	218	3	72.3	2	-	X
RPS6KA2	570	0	49.5	4	-	X
RSK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SBKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SGK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TBC1D4	570	9	43.0	0	-	X
TBC1D4	568	9	44.5	0	-	X
NDRG1	328	4	43.3	1	-	X
GSK3B	216	3	84.9	4	X	X
NDRG1	330	1	41.7	3	X	X
CDKN1B	157	0	56.2	60	X	X
CDKN1B	198	0	69.3	101	-	X
GSK3B	9	0	69.4	18	-	X
NDRG1	366	0	41.1	24	X	X
NDRG1	346	0	43.1	19	X	X
NDRG1	356	0	43.8	29	X	X
NDRG2	330	0	39.2	10	X	X
NDRG2	346	0	32.1	26	X	-
NDRG2	348	0	30.5	28	X	X
NDRG2	332	0	38.0	12	X	X
WNK4	1217	0	41.7	32	X	X
WNK4	1201	0	38.5	16	X	X
TSC2	981	0	28.1	4	X	X
TSC2	939	0	28.6	4	X	X
TBC1D4	341	0	27.4	5	-	X
WNK4	1190	0	36.6	5	X	X
TBC1D4	588	0	31.3	12	-	X
NEDD4L	342	0	27.1	27	X	X
NEDD4L	448	0	26.4	36	X	X
SGK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PTOV1	53	0	35.2	33	-	X
PTOV1	36	0	33.8	50	X	X
SGK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FLII	436	7	32.5	1	X	X
FLII	818	7	87.2	0	-	X
ITCH	385	7	92.2	0	-	X
ITCH	450	3	78.5	0	-	X
SIKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
skMLCKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLK	183	5	42.9	1	X	-
SLK	189	0	45.1	5	X	-
SMG1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
UPF1	1107	1	26.9	2	X	X
UPF1	28	0	34.4	63	X	X
UPF1	1089	0	30.1	15	X	X
UPF1	1127	0	34.2	22	-	X
UPF1	1084	0	30.5	20	-	X
smMLCKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MYL12B	19	8	68.8	0	-	X
MYL9	19	8	68.4	0	-	X
MYL12B	20	6	65.6	0	X	X
MYL9	20	6	65.5	0	-	X
Srcs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
EGFR	727	15	82.1	0	-	X
VIL1	64	15	91.8	0	-	X
HNF4A	288	14	94.4	0	X	X
MYLK	471	14	84.6	0	-	X
VIL1	256	14	86.7	0	-	X
BAIAP2L1	163	13	94.7	0	X	-
CORO7	288	13	93.2	0	-	X
CTNNB1	654	13	96.6	0	X	-
DVL2	295	13	86.0	0	-	X
EYA3	426	13	97.5	0	-	X
FLOT1	149	13	94.8	0	X	-
PTEN	155	13	97.2	0	X	-
PTEN	68	13	98.1	0	X	-
STAT3	68	13	92.8	0	X	-
BAIAP2L1	156	12	85.1	0	X	-
CTNNB1	333	5	98.7	1	X	X
ACLY	682	9	98.5	0	X	X
EYA3	508	10	98.4	0	-	X
PTEN	174	11	98.3	0	X	-
BAIAP2L1	37	9	98.2	0	X	-
AGO2	749	10	98.1	0	X	-
EYA3	325	10	98.0	0	X	-
G6PD	112	8	98.0	0	X	X
RGS16	168	12	98.0	0	X	X
CDC25A	486	5	97.9	3	-	X
CORO7	738	11	97.7	0	X	-
GIT1	284	12	97.7	0	-	X
CORO7	712	11	97.6	0	X	-
GSN	465	8	97.6	0	-	X
ACLY	252	9	96.1	0	X	X
ACLY	1006	11	97.4	0	X	X
ACLY	227	8	95.4	0	X	X
AFAP1	453	7	83.3	0	X	-
AGO2	529	9	95.9	0	X	-
AGO2	393	11	96.7	0	X	X
AKAP8	539	10	81.0	0	X	-
AKAP8	436	9	84.4	0	X	-
ANXA2	24	8	95.7	0	X	-
ARAF	302	5	73.5	0	X	-
ARAF	301	5	67.6	0	X	-
ATP1A1	149	9	76.0	0	-	X
ATP1A1	260	8	90.4	0	X	X
GBF1	876	12	93.8	0	X	X
GBF1	1567	12	92.5	0	X	-
GBF1	1244	12	92.0	0	X	-
EPS8	774	11	87.9	0	X	-
GRK2	86	11	95.8	0	X	-
DAPK1	491	11	95.9	0	X	X
DVL2	18	12	91.9	0	-	X
CORO7	758	11	96.3	0	X	X
GSN	603	12	97.2	0	-	X
PTEN	240	11	97.0	0	X	X
VIL1	46	12	90.8	0	-	X
PRKD1	432	11	89.7	0	X	-
PTEN	315	10	84.5	0	X	-
EZR	146	6	94.9	0	X	X
PRKCD	334	6	39.4	0	-	X
FUBP1	268	6	44.2	0	-	X
KIF11	231	7	66.8	1	X	X
PTPN6	536	6	40.1	1	X	X
DVL2	275	6	86.5	1	-	X
KCNA3	187	9	96.6	0	X	-
PTK2	1007	10	86.1	0	-	X
SDC4	180	4	56.9	2	X	X
SRC	419	7	66.8	0	X	X
CNKSR1	26	4	88.6	1	X	-
EGFR	915	4	90.7	0	X	X
G6PD	428	7	85.4	0	X	-
SRMSs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SRPK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SRPK1	587	12	97.2	0	-	X
RBM8A	168	0	53.9	17	-	X
RBM8A	166	0	50.1	15	-	X
SRPK1	309	0	35.3	13	X	X
SRPK1	33	0	38.3	10	X	X
SRPK1	326	0	36.2	30	X	X
SRSF1	219	0	34.3	25	-	X
SRSF1	209	0	37.1	15	-	X
SRSF1	223	0	34.4	29	-	X
SRSF1	215	0	33.3	21	-	X
SRSF1	207	0	37.7	13	-	X
SRSF1	225	0	35.2	31	-	X
SRSF1	211	0	36.0	17	-	X
SRSF1	213	0	34.8	19	-	X
SRSF1	221	0	34.5	27	-	X
SRSF1	227	0	37.9	33	-	X
SRSF1	205	0	36.5	11	-	X
SRSF1	217	0	34.2	23	-	X
SRPK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
STK33s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
STLK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLC12A1	100	8	67.9	0	X	X
SLC12A1	105	6	62.1	0	X	-
SLC12A3	55	6	66.0	0	-	X
SLC12A2	212	5	64.0	0	-	X
SLC12A3	60	4	59.5	1	-	X
SLC12A6	1048	2	57.9	5	-	X
SLC12A1	95	0	41.5	3	X	X
SLC12A2	207	0	31.1	4	-	X
SLC12A2	203	0	25.6	8	-	X
SLC12A3	46	0	25.6	8	-	X
SLC12A6	96	0	35.9	49	X	X
STYK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BECN1	93	0	34.6	16	X	-
BECN1	90	0	35.2	19	X	-
Syks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DUSP3	138	15	98.7	0	X	X
DUSP3	38	14	98.6	0	X	X
DOCK2	224	13	90.4	0	X	-
DOCK2	122	9	94.0	0	X	-
SLC4A1	8	9	62.0	0	X	X
DOCK2	1405	7	88.9	0	X	-
SYK	348	7	95.4	1	-	X
SYK	525	7	49.4	0	X	X
LAT2	193	5	75.3	1	X	-
SLC4A1	359	5	36.5	0	-	X
SYK	526	5	40.9	0	X	X
CBL	731	4	35.0	0	X	-
DOCK2	985	4	91.7	2	X	-
GCSAM	107	4	63.3	1	X	X
PLCG1	771	4	59.2	0	-	X
SYK	352	3	86.8	0	-	X
GCSAM	128	0	81.2	10	X	X
GCSAM	86	0	74.1	5	-	X
BLNK	96	0	70.7	14	X	X
LAT2	136	2	69.5	1	X	-
LAT2	233	0	69.3	18	X	-
BLNK	72	0	63.6	9	X	X
SLC4A1	904	4	46.6	0	-	X
BLNK	189	2	61.9	1	-	X
GCSAM	106	3	61.8	1	-	X
BLNK	84	2	61.6	2	X	X
BLNK	178	0	60.3	9	X	X
CBL	700	0	43.6	31	X	-
CBL	774	0	40.7	39	X	-
FCGR2A	304	0	47.8	5	-	X
SNCA	133	2	52.8	1	X	X
TAF1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
GTF2A1	321	4	63.1	1	X	X
GTF2A1	316	2	66.4	1	X	X
TAK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP3K7	187	9	55.7	0	X	X
HSP90B1	675	8	76.0	0	-	X
MAP3K7	184	7	50.5	0	X	X
MAP3K7	178	7	66.4	0	X	-
HSP90B1	674	6	74.6	0	-	X
MAP3K7	192	6	77.4	0	X	-
HSP90B1	669	3	70.5	1	-	X
IKBKB	177	3	67.2	1	-	X
IKBKB	181	3	71.2	2	-	X
GAPVD1	1013	0	25.8	19	-	X
GAPVD1	1012	0	25.9	20	-	X
TAB1	452	0	29.3	22	X	X
TAB1	456	0	30.5	18	X	X
TAB1	457	0	30.7	17	X	X
TAB1	453	0	29.4	21	X	X
TAO1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RND3	210	0	40.2	5	X	X
RND3	218	0	37.5	13	-	X
RND3	240	0	35.5	35	-	X
TAO2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RND3	210	0	40.2	5	X	X
RND3	218	0	37.5	13	-	X
RND3	240	0	35.5	35	-	X
TAO3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TBK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PELI1	80	13	85.8	0	-	X
IRF3	405	10	87.7	0	X	X
PELI1	76	10	89.4	0	-	X
DDAH2	245	9	94.6	0	X	-
HTT	13	9	68.1	0	X	X
HTT	16	9	70.8	0	X	X
OPTN	473	9	97.5	0	X	X
OPTN	513	9	79.0	0	X	X
SIKE1	185	9	92.1	0	-	X
SIKE1	198	9	63.5	0	-	X
SIKE1	188	9	87.3	0	-	X
SIKE1	133	9	91.8	0	-	X
SIKE1	187	9	89.1	0	-	X
SIKE1	190	9	82.9	0	-	X
IRF3	404	8	87.7	1	X	X
GABARAPL2	88	6	97.9	0	X	X
GABARAPL2	87	5	97.5	0	X	X
DDAH2	211	7	96.9	0	X	-
DDAH2	203	4	96.4	1	X	-
IRF5	293	4	96.0	0	X	X
DDAH2	253	4	93.5	0	X	-
PELI1	288	3	91.7	0	-	X
SQSTM1	403	7	91.1	0	X	X
IRF3	396	3	88.5	0	X	X
IRF3	402	6	87.8	0	X	X
SMCR8	796	8	78.0	0	-	X
AKT1	473	7	82.0	1	X	X
MAP1LC3C	93	6	79.3	1	X	X
AKT1	308	2	72.1	2	X	X
IRF3	386	5	84.4	2	X	X
IRF3	398	3	87.5	1	X	X
IRF3	385	5	83.1	1	-	X
MAP1LC3C	96	3	84.0	1	X	X
OPTN	177	2	42.6	1	X	X
PELI1	293	3	87.1	1	-	X
TECs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PTPN18	281	11	97.0	0	X	-
PTPN18	303	8	70.3	0	X	-
PTPN18	389	0	35.0	66	X	-
PTPN18	354	0	38.0	34	X	-
TESK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TGFBR1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ENG	646	0	47.8	29	X	-
ENG	649	0	51.2	32	X	-
SMAD2	467	0	84.8	12	X	X
SMAD2	465	0	85.2	10	X	X
SMAD2	464	0	85.1	9	X	X
TGFBR2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TGFBR2	259	15	96.2	0	-	X
TGFBR1	200	10	77.8	0	-	X
TGFBR2	336	9	98.3	0	-	X
TGFBR1	185	7	63.3	0	X	-
TGFBR1	191	7	75.9	4	X	-
TGFBR2	416	7	82.6	0	X	-
TGFBR2	424	7	96.9	0	-	X
TGFBR1	186	6	56.8	0	X	-
TGFBR1	187	5	56.2	0	X	-
TGFBR2	409	5	85.0	1	X	-
TGFBR1	189	4	66.7	2	X	-
ENG	634	0	40.0	17	X	-
ENG	635	0	39.8	18	X	-
TGFBR2	213	0	30.7	6	X	-
USP2	207	0	31.4	4	-	X
USP2	225	0	31.0	10	-	X
TGM2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
H3C1	10	0	None	100000	-	X
H3C1	28	0	None	100000	-	X
TIE2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TEK	1108	8	72.3	1	-	X
TEK	992	5	70.8	0	-	X
Titins, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TLK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAPKAPK5	386	9	68.4	0	-	X
NEK1	141	8	94.4	1	X	X
NEK1	14	5	68.1	0	-	X
NEK1	315	4	36.5	0	-	X
MAPKAPK5	354	3	69.6	0	X	X
AKTIP	237	2	93.4	3	X	X
MAPKAPK5	160	2	92.3	1	-	X
RAD9A	355	2	38.3	1	X	X
AKTIP	22	0	36.7	43	X	X
RAD9A	328	0	38.5	25	X	X
TLK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TNIKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
HTT	13	9	68.1	0	X	X
HTT	3	7	69.1	0	X	X
TNK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TNNI3Ks, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TRB2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TrkAs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PLCG1	771	4	59.2	0	X	-
PLCG1	783	0	28.5	10	X	-
TrkBs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
KCNA3	163	11	96.5	0	X	-
KCNA3	499	9	42.8	0	X	-
KCNA3	161	9	96.6	0	X	-
KCNA3	162	9	96.5	0	X	-
TrkCs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TSSK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TTBK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TTBK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SV2A	45	9	46.7	0	-	X
SV2A	42	9	51.2	0	-	X
SV2A	47	7	45.0	0	-	X
SV2A	84	0	37.5	35	-	X
SV2A	80	0	35.9	31	-	X
SV2A	81	0	37.2	32	-	X
TTKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
CDCA8	238	11	78.9	0	-	X
HSPA9	65	10	97.9	0	-	X
BUB1B	1043	9	58.2	1	X	-
BUB1B	435	9	88.7	0	X	-
CDCA8	230	9	81.0	0	-	X
MAD1L1	610	9	86.0	0	-	X
MAD1L1	62	9	88.5	0	-	X
MAD1L1	624	9	90.3	0	-	X
TTK	12	9	58.8	0	X	X
TTK	7	9	47.9	0	X	-
TTK	824	9	78.1	0	-	X
TTK	564	9	76.7	0	-	X
TTK	582	9	97.4	1	-	X
TTK	811	9	68.5	0	-	X
TTK	15	9	65.5	0	X	X
HSPA9	62	5	97.3	2	-	X
TTK	742	7	92.9	0	-	X
TTK	821	6	78.1	1	-	X
MAD1L1	323	6	77.4	0	-	X
BLM	1290	2	74.8	2	X	-
ARHGEF17	1007	8	35.9	0	-	X
CDCA8	94	6	57.0	0	-	X
CDCA8	88	6	55.3	0	-	X
MAD1L1	22	6	55.0	0	-	X
MAD1L1	8	7	58.7	0	-	X
MAD1L1	598	7	60.1	0	-	X
MAD1L1	716	5	74.0	0	X	X
ARHGEF17	944	0	30.6	59	-	X
ARHGEF17	751	0	29.5	45	-	X
BLM	1296	0	33.7	8	X	-
BLM	144	0	30.7	13	X	-
BUB1B	670	0	36.8	51	X	-
BUB1B	543	0	39.3	62	X	-
TTK	33	7	40.1	0	X	X
TTK	46	3	56.3	0	X	-
TTK	45	3	47.4	0	X	-
TTK	805	6	58.8	0	-	X
TTK	37	2	34.0	1	X	X
TTK	806	7	61.7	0	-	X
TXKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
TXK	91	6	82.5	2	-	X
TXK	420	4	87.6	0	-	X
Tyk2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
IFNAR1	466	7	71.9	0	-	X
SIVA1	53	7	72.0	0	X	-
TYK2	1055	4	89.8	4	-	X
TYK2	1054	3	90.7	3	-	X
SIVA1	162	1	80.3	2	X	-
TYK2	292	1	47.5	5	-	X
IFNAR1	481	0	43.2	13	-	X
Tyro3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ULK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ENO1	115	13	98.7	0	-	X
SEC23A	405	13	97.7	0	X	X
BECN1	337	11	91.6	1	X	-
HK1	124	10	97.7	0	X	X
SESN2	254	10	76.4	0	X	-
BECN1	279	9	90.4	0	X	-
ENO1	282	9	98.3	0	X	X
FBP1	88	9	97.2	0	-	X
RB1CC1	986	9	79.6	0	X	-
RB1CC1	943	9	77.2	0	X	-
RB1CC1	1323	9	76.4	0	X	-
RIPK1	296	9	95.0	0	-	X
RIPK1	291	9	96.5	0	-	X
RIPK1	262	9	97.3	0	-	X
SDCBP	6	9	94.3	1	X	-
ATG101	11	8	97.2	0	X	-
FLCN	406	7	96.5	0	X	X
HK1	364	6	96.1	1	-	X
FLCN	537	8	93.0	0	X	X
FLCN	542	8	92.9	2	X	X
PFKM	74	8	92.1	0	-	X
ATG101	203	5	63.8	0	X	-
BECN1	30	4	63.1	0	X	X
FBP1	63	5	81.4	0	X	X
RIPK1	320	6	69.4	0	-	X
AMBRA1	635	0	27.3	11	X	-
AMBRA1	465	0	28.0	38	X	-
ATG13	355	0	37.9	18	X	X
ATG13	389	0	41.4	4	X	-
ATG9A	761	0	30.3	38	X	X
ATG9A	14	0	34.2	6	X	X
SESN2	73	5	49.3	0	X	-
RPTOR	792	6	50.4	0	X	X
SDCBP	60	3	60.1	3	X	-
SEC23A	207	2	77.3	2	X	X
ULK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
RPTOR	792	6	50.4	0	X	-
DENND3	490	0	25.8	7	-	X
DENND3	472	0	26.3	7	-	X
RPTOR	855	0	31.2	10	X	-
RPTOR	859	0	30.1	14	X	-
ULK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ULK3	300	11	90.8	0	-	X
ULK3	350	9	79.8	0	-	X
ULK3	384	9	92.8	0	-	X
ULK3	464	8	49.9	0	-	X
VEGFR1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
FLT1	1327	2	34.2	1	-	X
FLT1	1213	0	28.8	15	X	X
FLT1	1169	0	43.2	3	X	X
FLT1	1333	0	28.6	7	-	X
FLT1	1242	0	31.2	12	-	X
VEGFR2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PFN1	129	11	97.5	0	-	X
KDR	1059	7	58.3	1	X	X
KDR	1054	4	38.7	0	X	X
KDR	996	4	48.9	0	X	X
KDR	1175	0	31.1	3	X	X
KDR	1214	0	35.0	7	X	X
KDR	951	0	27.5	6	X	X
VEGFR3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
VPRBPs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
VRK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ATF2	73	6	60.8	0	X	X
BANF1	4	5	89.9	1	X	X
JUN	73	5	63.4	0	X	X
BANF1	3	3	88.8	2	X	X
ATF2	62	0	45.1	10	X	X
BANF1	2	0	82.5	3	X	X
H3C1	3	0	None	100000	X	X
H3C1	10	0	None	100000	X	X
JUN	63	0	49.4	10	X	X
VRK1	376	0	38.5	44	-	X
VRK1	386	0	40.6	54	X	X
VRK1	355	0	29.1	23	-	X
VRK2 iso2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
VRK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
BANF1	4	5	89.9	1	-	X
USP25	680	4	84.8	0	-	X
USP25	727	4	41.2	0	-	X
BANF1	3	3	88.8	2	-	X
IKBKB	177	3	67.2	1	X	X
IKBKB	181	3	71.2	2	X	X
USP25	745	3	26.8	1	-	X
BANF1	2	0	82.5	3	-	X
DTNBP1	299	0	39.9	40	X	X
DTNBP1	297	0	41.3	38	X	X
VRK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Wee1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
WNK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLC12A6	991	9	66.6	0	X	-
PCF11	120	7	78.5	0	X	X
PCF11	121	7	81.6	0	X	X
OXSR1	325	5	44.8	0	-	X
STK39	371	5	42.8	1	-	X
SLC12A6	1048	2	57.9	5	X	-
STK39	231	2	44.6	4	-	X
OXSR1	185	0	42.3	5	-	X
WNK2s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
STK39	354	6	85.7	1	X	-
STK39	371	5	42.8	1	X	-
WNK3s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLC12A6	991	9	66.6	0	X	-
SLC12A6	1048	2	57.9	5	X	-
SLC12A6	96	0	35.9	49	X	-
WNK4s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
SLC12A3	55	6	66.0	0	X	-
SLC12A3	50	0	30.3	4	X	-
SLC12A3	46	0	25.6	8	X	-
WSTFs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
Yess, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
ALOX5	54	9	96.4	0	-	X
CDC37	298	9	83.3	0	X	X
PTK2	925	8	87.3	0	X	-
CDKN1B	89	5	91.7	0	-	X
ALOX5	446	4	98.2	1	-	X
CDC37	4	4	73.4	1	X	X
CDKN1B	88	4	91.9	0	-	X
ALOX5	43	3	88.6	1	-	X
CDKN1B	74	2	94.2	6	-	X
WBP2	231	2	49.7	2	X	-
PTK2	861	0	34.2	28	X	-
WBP2	192	0	38.7	25	X	-
YAP1	407	0	42.9	22	X	X
YAP1	391	0	40.5	6	X	X
YSK1s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
PDCD10	43	9	97.2	0	X	X
PDCD10	39	7	97.2	0	X	X
PRKAR1A	83	0	47.1	10	X	X
PRKAR1A	77	0	43.1	4	X	X
ZAKs, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
MAP3K20	165	2	55.1	2	X	X
MAP3K20	161	1	54.0	5	X	X
MAP3K20	162	0	43.1	5	X	X
ZAP70s, phosphosites to test:
site	Score	AFConf	NextAA	in_vivo	in_vitro	id_alphafold
DUSP3	138	15	98.7	0	X	X
DUSP3	38	14	98.6	0	X	X
ZAP70	597	13	88.9	0	X	-
ZAP70	598	11	86.2	0	X	-
ZAP70	126	11	89.9	0	-	X
THEMIS	540	10	83.3	0	X	X
THEMIS	95	10	91.9	0	-	X
THEMIS	353	10	82.1	0	-	X
THEMIS	541	9	76.6	0	X	X
THEMIS	429	7	79.3	0	-	X
THEMIS	174	7	91.6	0	-	X
ZAP70	315	7	95.9	1	-	X
ZAP70	319	5	91.6	0	-	X
ZAP70	292	4	56.2	17	-	X
ZAP70	493	2	46.8	0	X	X
LCP2	145	0	68.5	8	X	X
LCP2	113	0	60.7	39	X	X
ZAP70	492	2	36.5	1	X	X
DBNL	334	0	42.5	40	X	X
DBNL	344	0	39.3	30	X	X
LCP2	128	0	57.2	25	X	X
